Research Article | Vol. 2, Issue 2 | Journal of Clinical Medical Research | Open Access |
Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic
Asmaa Fathi Hamouda1,2*, Taymour-Lank Mohammed Farawilla3, Ibraheem Mohammed Attafi4, Ibrahim Abdu Khardali4, Mohammad Ahmad Attafi4, Magbool Essa Oraiby4, Farid Mohammad Abualsail4
1Department of Biochemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
2Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia
3Department of Chemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
4Poison Control and Medical Forensic Chemistry Center, Ministry of Health, Jazan, Kingdom of Saudi Arabia
*Corresponding Author: Asmaa Fathi Hamouda, Alexandria University, Egypt, Assistant Professor in the Umm Al-Qura University, Saudi Arabia (2014-2016) and Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia, Email: [email protected]
Citation: Hamouda AF, et al. Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic. J Clin Med Res. 2021;2(2) :1-65.
Copyright© 2021 by Hamouda AF, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received 24 Apr, 2021 | Accepted 13 May, 2021 | Published 20 May, 2021 |
Abstract
Background: Since 2019, several critical effects of the coronavirus pandemic have surfaced, including its psychological problems such as depression. The World Health Organization has approved a group of drugs and vaccines. However, the world still faces novel coronavirus mutations, requiring more ideas to investigate a drug, vaccine and phytochemical potential chemoprevention proposal. Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV)-2 co-operates directly with the Angiotensin-Converting Enzyme 2 (ACE2) to penetrate the target cells.
Aims: We aim to introduce the possibility of studying seed oil extract as an anti-depression, anti-stress, anti-epinephrine receptor (PDB: 2rh1) and as potentially binding anti-angiotensin-converting enzyme 2 (ACE2) agent.
Methods and Methodology: We analyze the constituents of the six studied seeds’ oil with Gas Chromatography-Mass Spectrometry (GC-MS) by performing an AutoDock analysis of the components’ potential ligands to both the 2rh1 and ACE2.
Results: We observe convenient binding conformations between the investigated receptors and the 44 phytoconstituents. The AutoDock outcomes of the seeds’ phytochemical GC-MS separated components reveal highly binding energy, with ACE2 higher than 2rh1.
Conclusion: The studied seed oil contains binding energy with currently studied receptors and molecular weight, which enables it to be studied in the future as a nanoparticle against viruses, vaccines and psychiatric drugs.
Keywords
Coronavirus; Depression; Seed Oil; Adrenaline; Angiotensin-Converting Enzyme 2; Autodock; Phytochemicals; Nanoparticles
Introduction
Fruit processing produces a significant quantity of wastes. The stones of fruits such as grapes (Vitis vinifera), plum (Prunus subg. Prunus: Mirabelles), apple (Malus domestic), Ajwa dates (Phoenix dactylifera L), pomegranate (Punica granatum) and avocado (Persea Americana) are the remains that are generally discarded as trash and can cause environmental problems [1,2]. Examining such underutilized wastes’ likely dietary and therapeutic potentials will also diminish the desirable environmental waste load such as river water toxicity. Seed composition depends on maturation, the environmental cultivation state and extraction protocol method that makes about 6 to 20% of the seed oil as fatty acid, vitamin and phytosterol. The seed oil compositions vary between fatty acids (oleic, palmitic, stearic, linoleic acid), vitamins (isomers tocopherol) and phytosterol (stigmasterol), according to the method of extraction [3,4].
Recently, the global coronavirus (COVID-19) pandemic has drawn scientists’ attention to the study of possible vaccines, herb and drug treatments and protection-potential medications [5,6]. The insertion of coronavirus into susceptive cells is complicated and needs some effort to assume the receptor-binding and proteolytic mechanism of virus-cell fusion. Coronaviruses (SARSr-CoV) co-operate directly with the Angiotensin-Converting Enzyme 2 (ACE2) to penetrate the target. Studies showed that ACE2 is expressed in the mouth, tongue and lower lungs on type I and II alveolar epithelial cells, promoting viral insertions in the host [6,7]. The previous mechanism helps infuse SARS-CoV-2 entry, exploits the endogenous transcriptional machinery of alveolar cells to replicate it and spreads it into the entire lung and body, where ACE2 is expressed in other organs, including the kidney, heart and gut [5-7].
ACE-1 and ACE-2 result in cleaving angiotensin peptides into angiotensin I (Ang 1) and generating angiotensin (Ang) II. Ang II has an inflammatory response that causes vasoconstriction, bronchoconstriction, increases vascular permeability and fibrosis. These previous action responses enhance Acute Respiratory Disease Syndrome (ARDS) and lung failure in patients infected with SARS-CoV-2 and that is different to the receptor number from one individual to another.
Carboxypeptidase (zinc metalloprotease) is known as ACE2, degrading Ang II to an anti-inflammatory Ang (1-7). Ang II’s conversion to Ang (1-7) by the enzyme ACE2 produces effects that oppose the Ang II-mediated action. The SARS-CoV-2 virus infects alveolar pneumocytes by binding to ACE2, leading to a decrease in Ang II conversion to ACE2-derived peptides; for instance, a reduction in Ang (1-7) and its anti-inflammatory effects prevent the effects of Ang II and led to a higher imbalance between ACE1 and ACE2. The disturbance starts a storm of an inflammatory reaction and thus, the immune response will be overcome [6,8].
Although some animal studies proposed that the application of ACEIs could provide the inhibition of and treatment for the consequences of the COVID-19 infection, different scenarios indicate that their use may increase the infection’s deleterious conditions. Therefore, more trials need to provide evidence of their effectiveness. The potential benefit-risk study of the traditional drugs and herb extracts during COVID-19 connected with other issues such as hypertension, heart failure and gut, colon and renal disease associated with diabetes should also be discussed. Further, the psychiatric consequences during the COVID-19 pandemic should be taken into consideration [5].
A previous study reported that the coronavirus (COVID-19) pandemic produced significant distress to patients with chronic illnesses, including the emotional state and perception, especially among patients with inflammatory bowel diseases [9].
Our previous study reported that dietary intake of vitamins, especially B6, B9 and B12 and herb extracts such as agarwood significantly affect mood and stress and decrease inflammation through β2 adrenoreceptor (2rh1) binging energy [10]. Moreover, the combination of the beta-adrenergic receptor block and renin-angiotensin system inhibition throughout diminished the Ang II-induced inflammatory cascade reaction and increased Ang (1-7) as well as its anti-inflammatory effects [11-13].
We hypothesize that the seed oil extract can affect both receptors and have a potential beneficial effect in decreasing the entry of viruses in the human body, decreasing storm inflammatory outcomes and improving the mood, thus decreasing stress in the COVID-19 pandemic. From this point of view, we aim to study seed oil extract as an anti-depression, anti-stress and anti-epinephrine receptor (PDB: 2rh1) ACE2.
Material and Methods
Plant Study
Plant Materials
We obtained grape (Vitis vinifera), plum (Prunus subg. Prunus: Mirabelles), apple (Malus domestic), Ajwa dates (Phoenix dactylifera L), pomegranate (Punica granatum) and avocado (Persea Americana) seeds from fruits that were collected from a local market in Saudi Arabia for this study. Here, supplementary Fig. 1 shows the experimental design. Seeds were crushed in the crushing machine and extracted with a solvent (1: 5 w/v), where the solvent compositions were hexane and ethanol (1:1). After being soaked in the solvent for 10 minutes at room temperature (28 ± 2°C), the extracts were separately concentrated with a 40-50°C rotary evaporator 14-23. The ground seeds extracted independently with (n-hexane: absolute ethanol) as (1:1) yielded 6%, 35%, 5%, 21%, 15% and 68% oil, respectively and named as GSO(Grapes (Vitis vinifera) extracts), PSO (Plum (Prunus subg. Prunus: Mirabelles) extracts), ASO (Apple (Malus domestic) extracts), AWSO (Ajwa dates (Phoenix dactylifera L) extracts), PGSO (Pomegranate (Punica granatum) extracts), AVSO (Avocado (Persea Americana) extracts).
Figure 1: Experimental design. *Abbreviations: GSO: Grapes (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts; GC-MS: Gas Chromatography-Mass Spectrometry; 2RH1: Epinephrine receptor; ACE2: Angiotensin-converting enzyme 2.
Gas Chromatography-Mass Spectrometry Analysis
We followed our previous method for the Gas Chromatography-Mass Spectrometry (GC-MS) analysis to separate the chemical constituents of the extract using a gas chromatography system (G3440B, Agilent Technologies, USA) [24].
The seeds extracts were re-dissolved in ethanol and filtered using a nylon 0.45 μm pore size membrane filter separately. The GC-MS analysis was performed using a general screening method [24]. The separation column was from Thermo Fisher Scientific (TR-5MS) and had the following properties: 30 m length, Internal Diameter (ID) 0.25 mm and film thickness 0.25 µm. The carrier gas was helium and the flow rate was 1 ml/min. A total of 2 µl of each sample was injected into splitless mode at an injection port with a temperature of 260ºC. The GC thermal program started at 80ºC and was conducted for 1.5 min. Next, the thermal program increased at the first ramp to 210ºC at a rate of 30ºC/min and then the rate was slowed to 20ºC/min to reach the final temperature of 320ºC; this temperature was held for 11 min. The ion source in MS was Electron Ionization (EI) and the analysis was conducted in a scanning mode with an electron energy of 70 eV. The ion source and transfer line temperatures were adjusted to 230ºC. The composites of the plant extract were identified by computer explorations in the commercial libraries of Wiley and NIST (National Institute of Standards and Technology).
We then searched the Wiley and NIST mass spectral libraries to identify the chemical components of the seeds extract [24]. Furthermore, we screened the unique seed extracts separately for components with AutoDock to determine their potential as ligands of the anti-epinephrine receptor (PDB: 2rh1) and ACE2 to provide more convincing proof of the therapeutic opportunities provided by GSO, PSO, ASO, AWSO, PGSO and AVSO [25,26].
Autodock Analysis
Preparation of the modelled epinephrine receptor (PDB: 2rh1), Angiotensin-Converting Enzyme 2 (ACE2) and specific GSO, PSO, ASO, AWSO, PGSO and AVSO components for docking
The AutoDock Vina 4.2 software includes procedures for optimizing proteins and ligands, such as allowing atomic charges to make proteins more polar [26-29]. Proteins and ligands were adjusted through the charge and rotatable bond authorization, consideration of the energy contribution of desolvation through the binding of a ligand to the protein and previous naming of grid maps of the protein surface for synergy ligands by the auto grid. These tools increase the speed and accuracy of docking with a unique scoring capacity, optimize effectively and perform the multithreading of the molecular docking [26-29].
Result and Discussion
GC-MS Analysis Outcomes
The GC-MS analysis identified the chemical composition of GSO, PSO, ASO, AWSO, PGSO and AVSO extracts. The specific components that are unique to the extract are presented in Table 1-6, which include the chemical name, molecular weight, retention time and area percentage. Besides, Table 7 illustrates the results of the GC-MS chromatogram of the selected compounds in the studied seeds, namely, GSO, PSO, ASO, AWSO, PGSO and AVSO.
Area | Name | Formula | Mass (DB) | Base Peak | RT | Score (Lib) | CAS | Library |
1153381 | 9-Octadecenamide, (Z)– | C18H35NO | 281.3 | 59 | 14.014 | 96.01 | 301-02-0 | NIST11.L |
553719 | 9-Octadecenamide, (Z)– | C18H35NO | 281.3 | 59 | 14.068 | 95.12 | 301-02-0 | NIST11.L |
312347 | 9-Octadecenamide, (Z)– | C18H35NO | 281.3 | 59 | 14.132 | 80.8 | 301-02-0 | NIST11.L |
253901 | Stigmastan-3,5-diene | C29H48 | 396.4 | 396.4 | 19.823 | 82.64 | 1000214-16-4 | NIST11.L |
196415 | 9,12-Octadecadienoic acid (Z,Z)-, methyl ester | C19H34O2 | 294.3 | 81.1 | 12.335 | 88.67 | 112-63-0 | NIST11.L |
163338 | Oleamide | C18H35NO | 281 | 59 | 15.137 | 69.43 | 301-02-0 | SWGDRUG.L |
159068 | 9-Octadecenoic acid (Z)-, methyl ester | C19H36O2 | 296.3 | 55 | 12.367 | 79.86 | 112-62-9 | NIST11.L |
151791 | Stigmastan-3,5-diene | C29H48 | 396.4 | 145.1 | 18.24 | 70.76 | 1000214-16-4 | NIST11.L |
122124 | Hexadecanamide | C16H33NO | 255.3 | 59 | 12.944 | 86.69 | 629-54-9 | NIST11.L |
117526 | Phosphoric acid, trimethyl ester | C3H9O4P | 140 | 110 | 3.274 | 90.14 | 512-56-1 | NIST11.L |
85055 | Dodecyl acrylate | C15H28O2 | 240.2 | 55 | 9.575 | 89.7 | 2156-97-0 | NIST11.L |
61663 | Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters | C19H30O3 | 306.2 | 191.2 | 8.28 | 61.18 | 166273-38-7 | NIST11.L |
59729 | Methyl stearate | C19H38O2 | 298.3 | 74 | 12.501 | 73.68 | 112-61-8 | NIST11.L |
46671 | 1-Pentadecyne | C15H28 | 208.2 | 55 | 12.736 | 75.63 | 765-13-9 | NIST11.L |
45722 | Hexadecanoic acid, methyl ester | C17H34O2 | 270.3 | 74 | 11.217 | 88.84 | 112-39-0 | NIST11.L |
32926 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 282.3 | 207 | 14.656 | 65.15 | 1000130-81-0 | NIST11.L |
32557 | 4-Methyl-2,4-bis(4’-trimethylsilyloxyphenyl)pentene-1 | C24H36O2Si2 | 412.2 | 207 | 21.984 | 60.24 | 1000283-56-8 | NIST11.L |
25237 | 1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)- | C22H18O5 | 362.1 | 135.1 | 5.67 | 80.17 | 1000330-77-7 | NIST11.L |
20103 | 2-Bromotetradecane | C14H29Br | 276.1 | 71.1 | 9.543 | 71.68 | 74036-95-6 | NIST11.L |
12553 | Cyclotrisiloxane, hexamethyl- | C6H18O3Si3 | 222.1 | 207 | 17.443 | 62.3 | 541-05-9 | NIST11.L |
11645 | Isooctyl 3-mercaptopropionate | C11H22O2S | 218.1 | 57 | 11.907 | 66.69 | 30374-01-7 | NIST11.L |
Table 1: Results of the GC-MS analysis of the Grape Seed Extract (GSO).
Area | Name | Formula | Score | Mass (DB) | Base Peak | RT | CAS | Library |
1754219 | 9-Octadecenamide, (Z)– | C18H35NO | 95.39 | 281.3 | 59 | 14.014 | 301-02-0 | NIST11.L |
837978 | 9-Octadecenamide, (Z)– | C18H35NO | 94.8 | 281.3 | 59 | 14.073 | 301-02-0 | NIST11.L |
412230 | 9,12-Octadecadienoic acid (Z,Z)– | C18H32O2 | 74.12 | 280.2 | 55 | 12.709 | 60-33-3 | NIST11.L |
354051 | Octadecanamide | C18H37NO | 82.57 | 283.3 | 59 | 14.132 | 124-26-5 | NIST11.L |
336429 | 9-Octadecenoic acid, methyl ester, (E)– | C19H36O2 | 91.3 | 296.3 | 55 | 12.367 | 1937-62-8 | NIST11.L |
335665 | 9-Octadecenamide, (Z)– | C18H35NO | 76.36 | 281.3 | 59 | 15.137 | 301-02-0 | NIST11.L |
295258 | Benzamide, N-(1,3-dihydro-2-oxo-4-isobenzofuryl)– | C15H11NO3 | 67.17 | 253.1 | 105 | 3.563 | 1000270-36-9 | NIST11.L |
248784 | Squalene | C30H50 | 88.57 | 410.4 | 69.1 | 16.539 | 111-02-4 | NIST11.L |
201429 | Hexadecanamide | C16H33NO | 88.56 | 255.3 | 59 | 12.944 | 629-54-9 | NIST11.L |
200337 | 9,12-Octadecadienoic acid (Z,Z)-, methyl ester | C19H34O2 | 90.13 | 294.3 | 81.1 | 12.335 | 112-63-0 | NIST11.L |
196440 | Dodecyl acrylate | C15H28O2 | 89.05 | 240.2 | 55 | 9.575 | 2156-97-0 | NIST11.L |
133468 | Stigmastan-3,5-diene | C29H48 | 70.87 | 396.4 | 396.4 | 19.817 | 1000214-16-4 | NIST11.L |
103286 | cis-11-Hexadecenal | C16H30O | 72.19 | 238.2 | 55 | 14.271 | 53939-28-9 | NIST11.L |
99402 | Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters | C19H30O3 | 64.7 | 306.2 | 191.2 | 8.275 | 166273-38-7 | NIST11.L |
90774 | Oleamide | C18H35NO | 68.81 | 281 | 59 | 16.474 | 301-02-0 | SWGDRUG.L |
80042 | Stigmastan-3,5-diene | C29H48 | 61.13 | 396.4 | 207 | 18.245 | 1000214-16-4 | NIST11.L |
71117 | Hexadecane | C16H34 | 60.94 | 226.3 | 71.1 | 7.874 | 544-76-3 | NIST11.L |
70968 | Propanoic acid, 3-mercapto-, dodecyl ester | C15H30O2S | 81.54 | 274.2 | 57.1 | 11.901 | 6380-71-8 | NIST11.L |
62331 | Methyl stearate | C19H38O2 | 80.22 | 298.3 | 74 | 12.5 | 112-61-8 | NIST11.L |
59517 | 1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)- | C22H18O5 | 80.78 | 362.1 | 135.1 | 5.676 | 1000330-77-7 | NIST11.L |
56219 | Hexadecanoic acid, methyl ester | C17H34O2 | 88.83 | 270.3 | 74 | 11.217 | 112-39-0 | NIST11.L |
53892 | 1,2-15,16-Diepoxyhexadecane | C16H30O2 | 64.14 | 254.2 | 67 | 14.528 | 1000192-65-0 | NIST11.L |
45286 | Dodecane, 1-iodo- | C12H25I | 73.33 | 296.1 | 71.1 | 9.543 | 4292-19-7 | NIST11.L |
41330 | Oxalic acid, cyclobutyl octadecyl ester | C24H44O4 | 64.72 | 396.3 | 55 | 13.554 | 1000309-70-8 | NIST11.L |
31933 | (R)-(-)-14-Methyl-8-hexadecyn-1-ol | C17H32O | 73.75 | 252.2 | 67 | 12.912 | 64566-18-3 | NIST11.L |
28347 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 66.06 | 282.3 | 207 | 14.656 | 1000130-81-0 | NIST11.L |
21037 | Cyclotrisiloxane, hexamethyl- | C6H18O3Si3 | 61.01 | 222.1 | 207 | 29.14 | 541-05-9 | NIST11.L |
Table 2: Results of the GC-MS analysis of the Plum Seed Extract (PSO).
Area | Name | Formula | Score | Mass (DB) | Base Peak | RT | CAS | Library |
6889234 | 9-Octadecenamide, (Z)– | C18H35NO | 94.13 | 281.3 | 59 | 14.03 | 301-02-0 | NIST11.L |
2945751 | 9-Octadecenamide, (Z)– | C18H35NO | 93.78 | 281.3 | 59 | 14.089 | 301-02-0 | NIST11.L |
1033287 | cis-Vaccenic acid | C18H34O2 | 88.05 | 282.3 | 55.1 | 12.688 | 506-17-2 | NIST11.L |
1008732 | 9-Octadecenamide, (Z)– | C18H35NO | 86.69 | 281.3 | 59 | 14.142 | 301-02-0 | NIST11.L |
954396 | cis-11-Eicosenamide | C20H39NO | 88.97 | 309.3 | 59 | 15.143 | 10436-08-5 | NIST11.L |
610895 | Hexadecanamide | C16H33NO | 90.15 | 255.3 | 59 | 12.95 | 629-54-9 | NIST11.L |
593475 | cis-11-Eicosenamide | C20H39NO | 89.3 | 309.3 | 59 | 15.175 | 10436-08-5 | NIST11.L |
388532 | Benzoic acid | C7H6O2 | 90.25 | 122 | 105 | 5.456 | 65-85-0 | NIST11.L |
323156 | 9-Octadecenoic acid (Z)–, methyl ester | C19H36O2 | 94.1 | 296.3 | 55 | 12.367 | 112-62-9 | NIST11.L |
267970 | 13-Docosenamide, (Z)– | C22H43NO | 83.16 | 337.3 | 59 | 16.48 | 112-84-5 | NIST11.L |
240133 | Squalene | C30H50 | 83.22 | 410.4 | 69.1 | 16.539 | 111-02-4 | NIST11.L |
220504 | 9,12-Octadecadienoic acid (Z,Z)–, methyl ester | C19H34O2 | 85.99 | 294.3 | 55.1 | 12.34 | 112-63-0 | NIST11.L |
166826 | 2-pyrrolidinovalerophenone | C15H21NO | 61.27 | 231.2 | 126 | 4.483 | 1000379-01-6 | NIST11.L |
160890 | 9,12-Octadecadienoic acid (Z,Z)– | C18H32O2 | 80.2 | 280.2 | 55 | 12.843 | 60-33-3 | NIST11.L |
156823 | 2-Furancarboxaldehyde, 5-methyl- | C6H6O2 | 68.01 | 110 | 110 | 3.568 | 620-02-0 | NIST11.L |
149932 | 2,5,5-Trimethyl-3-hexyn-2-ol | C9H16O | 62.81 | 140.1 | 125.1 | 4.173 | 1522-16-3 | NIST11.L |
149396 | dl-.alpha.-Tocopherol | C29H50O2 | 84.28 | 430.4 | 165.1 | 20.026 | 10191-41-0 | NIST11.L |
148913 | 13-Tetradecenal | C14H26O | 69.47 | 210.2 | 55 | 14.271 | 85896-31-7 | NIST11.L |
145902 | Dodecyl acrylate | C15H28O2 | 77.77 | 240.2 | 55 | 9.575 | 2156-97-0 | NIST11.L |
134293 | 9-Octadecenamide, (Z)– | C18H35NO | 71.12 | 281.3 | 59 | 15.26 | 301-02-0 | NIST11.L |
115541 | Phosphoric acid, trimethyl ester | C3H9O4P | 76.47 | 140 | 110 | 3.269 | 512-56-1 | NIST11.L |
114363 | 9-Octadecenoic acid (Z)–, methyl ester | C19H36O2 | 87.2 | 296.3 | 55 | 12.393 | 112-62-9 | NIST11.L |
104507 | 9,12-Octadecadienoic acid (Z,Z)–, phenylmethyl ester | C25H38O2 | 68.52 | 370.3 | 91.1 | 16.314 | 47557-83-5 | NIST11.L |
99081 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | C6H8O4 | 78.5 | 144 | 43 | 5.109 | 28564-83-2 | NIST11.L |
89982 | 7-Decen-1-ol acetate | C12H22O2 | 65.77 | 198.2 | 198.1 | 10.58 | 1000130-98-7 | NIST11.L |
73813 | 13-Octadecenal, (Z)– | C18H34O | 74.15 | 266.3 | 55 | 13.554 | 58594-45-9 | NIST11.L |
Table 3: Results of the GC-MS analysis of the Apple Seed Extract (ASO).
Area | Name | Formula | Score | Mass (DB) | Base Peak | RT | CAS | Library |
11938939 | 5-Hydroxymethylfurfural | C6H6O3 | 93.69 | 126 | 97 | 5.981 | 67-47-0 | NIST11.L |
7187956 | 9-Octadecenamide, (Z)– | C18H35NO | 93.41 | 281.3 | 59 | 14.036 | 301-02-0 | NIST11.L |
2795712 | Oleic Acid | C18H34O2 | 89.41 | 282.3 | 55.1 | 12.688 | 112-80-1 | NIST11.L |
2786153 | 9-Octadecenamide, (Z)– | C18H35NO | 92.81 | 281.3 | 59 | 14.089 | 301-02-0 | NIST11.L |
1941282 | 5-Methyl-2-pyrazinylmethanol | C6H8N2O | 71.12 | 124.1 | 95 | 4.526 | 61892-95-3 | NIST11.L |
1755089 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | C6H8O4 | 85.74 | 144 | 144.1 | 5.13 | 28564-83-2 | NIST11.L |
1340413 | 9-Octadecenamide, (Z)– | C18H35NO | 85.7 | 281.3 | 59 | 14.143 | 301-02-0 | NIST11.L |
1137031 | cis-11-Eicosenamide | C20H39NO | 88.05 | 309.3 | 59 | 15.143 | 10436-08-5 | NIST11.L |
1010531 | Hexadecanamide | C16H33NO | 89.11 | 255.3 | 59 | 12.955 | 629-54-9 | NIST11.L |
913214 | .alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl | C18H32O16 | 68.86 | 504.2 | 60 | 8.575 | 597-12-6 | NIST11.L |
523476 | Dodecanoic acid | C12H24O2 | 62.4 | 200.2 | 101 | 7.232 | 143-07-7 | NIST11.L |
519466 | Palmitic Acid | C16H32O2 | 82.97 | 256 | 73 | 11.554 | 57-10-3 | SWGDRUG.L |
464464 | 2,4-Dimethyl-3-pentanol acetate | C9H18O2 | 68.65 | 158.1 | 115.1 | 4.938 | 84612-74-8 | NIST11.L |
454918 | .alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl | C18H32O16 | 62.2 | 504.2 | 97 | 6.751 | 597-12-6 | NIST11.L |
445645 | d-Glycero-l-gluco-heptose | C7H14O7 | 69.94 | 210.1 | 73 | 9.457 | 1000130-14-6 | NIST11.L |
422390 | 7-Methyl-Z-tetradecen-1-ol acetate | C17H32O2 | 60.7 | 268.2 | 71 | 7.516 | 1000130-99-6 | NIST11.L |
384795 | Dodecanoic acid | C12H24O2 | 62.21 | 200.2 | 97 | 7.088 | 143-07-7 | NIST11.L |
343639 | .alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl | C18H32O16 | 69.04 | 504.2 | 43 | 4.226 | 597-12-6 | NIST11.L |
338707 | 9-Octadecenoic acid (Z)–, methyl ester | C19H36O2 | 93.39 | 296.3 | 55.1 | 12.367 | 112-62-9 | NIST11.L |
306881 | Levoglucosenone | C6H6O3 | 74.73 | 126 | 98 | 4.836 | 37112-31-5 | NIST11.L |
275232 | 13-Docosenamide, (Z)– | C22H43NO | 82.89 | 337.3 | 59 | 16.48 | 112-84-5 | NIST11.L |
261583 | Squalene | C30H50 | 74.99 | 410.4 | 69.1 | 16.539 | 111-02-4 | NIST11.L |
243810 | Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester | C9H14O3 | 68.54 | 170.1 | 141.1 | 6.371 | 66692-75-9 | NIST11.L |
229093 | 7,10-Octadecadienoic acid, methyl ester | C19H34O2 | 86.45 | 294.3 | 55.1 | 12.34 | 56554-24-6 | NIST11.L |
194471 | Stigmastan-3,5-diene | C29H48 | 79.33 | 396.4 | 396.4 | 19.828 | 1000214-16-4 | NIST11.L |
180044 | 1H-Inden-1-ol, 2,3-dihydro- | C9H10O | 66.21 | 134.1 | 133.1 | 5.815 | ######## | NIST11.L |
166539 | Phenol, 2,6-bis(1,1-dimethylethyl)- | C14H22O | 64.8 | 206.2 | 191.2 | 8.27 | 128-39-2 | NIST11.L |
144137 | Dodecanoic acid, 3-hydroxy- | C12H24O3 | 75.86 | 216.2 | 73 | 9.58 | 1883-13-2 | NIST11.L |
135632 | Stigmastan-3,5-diene | C29H48 | 71.22 | 396.4 | 145.1 | 18.245 | 1000214-16-4 | NIST11.L |
129752 | Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester | C9H15ClO3 | 63.1 | 206.1 | 57 | 5.676 | 1000195-30-2 | NIST11.L |
129419 | 9-Octadecenamide, (Z)– | C18H35NO | 73.1 | 281.3 | 59 | 15.26 | 301-02-0 | NIST11.L |
124757 | 7-Methyl-Z-tetradecen-1-ol acetate | C17H32O2 | 67.8 | 268.2 | 109 | 11.907 | 1000130-99-6 | NIST11.L |
Table 4: Results of the GC-MS analysis of the AJWA DATE SEED EXTRACT (AWSO).
Area | Name | Formula | Score | Mass (DB) | Base Peak | RT | CAS | Library |
7881254 | 9-Octadecenamide, (Z)– | C18H35NO | 94.13 | 281.3 | 59 | 14.035 | 301-02-0 | NIST11.L |
3678871 | 9-Octadecenamide, (Z)– | C18H35NO | 93.57 | 281.3 | 59 | 14.094 | 301-02-0 | NIST11.L |
2484499 | Squalene | C30H50 | 94.66 | 410.4 | 69.1 | 16.544 | 111-02-4 | NIST11.L |
1890724 | .gamma.-Tocopherol | C28H48O2 | 94.32 | 416.4 | 416.4 | 19.052 | 7616-22-0 | NIST11.L |
1614995 | Octadecanamide | C18H37NO | 87.45 | 283.3 | 59 | 14.142 | 124-26-5 | NIST11.L |
1306538 | cis-11-Eicosenamide | C20H39NO | 86.97 | 309.3 | 59 | 15.143 | 10436-08-5 | NIST11.L |
851742 | cis-11-Eicosenamide | C20H39NO | 86.97 | 309.3 | 59 | 15.18 | 10436-08-5 | NIST11.L |
809801 | Hexadecanamide | C16H33NO | 91.31 | 255.3 | 59 | 12.95 | 629-54-9 | NIST11.L |
731639 | 13-Docosenamide, (Z)– | C22H43NO | 93.29 | 337.3 | 59 | 16.48 | 112-84-5 | NIST11.L |
670773 | 5-Hydroxymethylfurfural | C6H6O3 | 78.42 | 126 | 97 | 5.815 | 67-47-0 | NIST11.L |
329977 | 9,12-Octadecadienoic acid (Z,Z)– | C18H32O2 | 83.51 | 280.2 | 55 | 12.688 | 60-33-3 | NIST11.L |
259024 | Stigmastan-3,5-diene | C29H48 | 82.99 | 396.4 | 396.4 | 19.823 | 1000214-16-4 | NIST11.L |
236786 | 9-Octadecenamide, (Z)– | C18H35NO | 72.37 | 281.3 | 59 | 15.26 | 301-02-0 | NIST11.L |
183380 | 9-Octadecenoic acid, methyl ester, (E)– | C19H36O2 | 90.67 | 296.3 | 55.1 | 12.367 | 1937-62-8 | NIST11.L |
177775 | Stigmastan-3,5-diene | C29H48 | 71.73 | 396.4 | 145.1 | 18.245 | 1000214-16-4 | NIST11.L |
155592 | Dodecyl acrylate | C15H28O2 | 86.06 | 240.2 | 55 | 9.58 | 2156-97-0 | NIST11.L |
136483 | 7-Hexadecenal, (Z)– | C16H30O | 74.64 | 238.2 | 55 | 13.554 | 56797-40-1 | NIST11.L |
132310 | Oleamide | C18H35NO | 76.78 | 281 | 59 | 14.271 | 301-02-0 | SWGDRUG.L |
127624 | Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters | C19H30O3 | 65.87 | 306.2 | 191.2 | 8.27 | 166273-38-7 | NIST11.L |
122878 | Oleanitrile | C18H33N | 88.92 | 263.3 | 55 | 12.334 | 1000308-88-1 | NIST11.L |
121687 | Octadecanoic acid | C18H36O2 | 77.44 | 284.3 | 55 | 12.843 | 57-11-4 | NIST11.L |
98579 | n-Hexadecanoic acid | C16H32O2 | 75.86 | 256.2 | 73 | 11.554 | 57-10-3 | NIST11.L |
88320 | Erucic Acid | C22H42O2 | 73.59 | 338 | 55.1 | 14.656 | 112-86-7 | SWGDRUG.L |
Table 5: Results of the GC-MS analysis of the Pomegranate Seed Extract (PGSO).
Area | Name | Formula | Score | Mass (DB) | Base Peak | RT | CAS | Library |
2897082 | Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro- | C20H36 | 69.15 | 276.3 | 94.1 | 12.297 | 14113-80-5 | NIST11.L |
2811595 | 9-Octadecenamide, (Z)– | C18H35NO | 93.38 | 281.3 | 59 | 14.02 | 301-02-0 | NIST11.L |
2745454 | 2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro- | C22H40O2 | 80.95 | 336.3 | 81.1 | 12.891 | 56599-50-9 | NIST11.L |
2319924 | E,Z-3,13-Octadecadien-1-ol acetate | C20H36O2 | 80.52 | 308.3 | 81.1 | 10.372 | 1000130-91-2 | NIST11.L |
1680890 | 1-Hexadecyn-3-ol, 3,7,11,15-tetramethyl- | C20H38O | 73 | 294.3 | 69 | 13.11 | 29171-23-1 | NIST11.L |
1357304 | Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)- | C21H34O2 | 80.78 | 318.3 | 94.1 | 13.351 | 57344-99-7 | NIST11.L |
1283909 | Z,E-2,13-Octadecadien-1-ol | C18H34O | 76.45 | 266.3 | 85 | 13.581 | 1000131-10-3 | NIST11.L |
1250645 | Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro- | C20H36 | 81.34 | 276.3 | 94 | 11.752 | 14113-80-5 | NIST11.L |
1092568 | Chrysene, octadecahydro- | C18H30 | 75.03 | 246.2 | 94.1 | 10.923 | 2090-14-4 | NIST11.L |
1058031 | 9-Octadecenamide, (Z)– | C18H35NO | 92.94 | 281.3 | 59 | 14.078 | 301-02-0 | NIST11.L |
1009366 | 9-Octadecenamide, (Z)– | C18H35NO | 83.68 | 281.3 | 59 | 14.137 | 301-02-0 | NIST11.L |
849953 | cis-11-Eicosenamide | C20H39NO | 83.93 | 309.3 | 59 | 15.143 | 10436-08-5 | NIST11.L |
782505 | Bicyclo[10.8.0]eicosane, (E)– | C20H38 | 75.55 | 278.3 | 81 | 11.789 | 1000155-85-0 | NIST11.L |
674421 | Hexadecanamide | C16H33NO | 68.87 | 255.3 | 69 | 12.95 | 629-54-9 | NIST11.L |
592928 | dl-.alpha.-Tocopherol | C29H50O2 | 94.47 | 430.4 | 430.4 | 20.026 | 10191-41-0 | NIST11.L |
559398 | Bicyclo[10.6.0]octadeca-1(12),15-diene | C18H30 | 82.51 | 246.2 | 94.1 | 10.334 | 1000155-85-1 | NIST11.L |
558452 | Formic acid, 3,7,11-trimethyl-1,6,10-dodecatrien-3-yl ester | C16H26O2 | 74.54 | 250.2 | 121 | 13.779 | 1000132-11-0 | NIST11.L |
540335 | cis-10-Nonadecenoic acid | C19H36O2 | 76.96 | 296.3 | 85.1 | 14.699 | 73033-09-7 | NIST11.L |
517071 | Bicyclo[10.6.0]octadeca-1(12),15-diene | C18H30 | 79.35 | 246.2 | 81.1 | 10.596 | 1000155-85-1 | NIST11.L |
504483 | Farnesol isomer a | C15H26O | 80.22 | 222.2 | 69 | 13.297 | 1000108-92-4 | NIST11.L |
486502 | 3-Chloropropionic acid, heptadecyl ester | C20H39ClO2 | 86.52 | 346.3 | 55 | 9.58 | 1000283-05-1 | NIST11.L |
445890 | Z,Z-4,6-Nonadecadien-1-ol acetate | C21H38O2 | 74.05 | 322.3 | 95.1 | 13.971 | 1000131-08-4 | NIST11.L |
438822 | cis-9-Hexadecenoic acid, trimethylsilyl ester | C19H38O2Si | 66.59 | 326.3 | 117 | 13.709 | 1000333-19-8 | NIST11.L |
422108 | 2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro- | C22H40O2 | 82.98 | 336.3 | 85.1 | 15.715 | 56599-50-9 | NIST11.L |
372034 | 9,12-Octadecadienoic acid (Z,Z)– | C18H32O2 | 81.92 | 280.2 | 55 | 12.709 | 60-33-3 | NIST11.L |
345493 | 2H-Pyran, 2-(7-dodecynyloxy)tetrahydro- | C17H30O2 | 74.06 | 266.2 | 85 | 14.586 | 16695-32-2 | NIST11.L |
319949 | 12-Methyl-E,E-2,13-octadecadien-1-ol | C19H36O | 77.79 | 280.3 | 69 | 14.276 | 1000130-90-4 | NIST11.L |
308267 | 1-Heptatriacotanol | C37H76O | 81.96 | 536.6 | 95.1 | 16.148 | 105794-58-9 | NIST11.L |
267929 | Oleic Acid | C18H34O2 | 70.63 | 282.3 | 55 | 11.538 | 112-80-1 | NIST11.L |
251122 | Stigmastan-3,5-diene | C29H48 | 83.63 | 396.4 | 396.4 | 19.828 | 1000214-16-4 | NIST11.L |
227979 | Cyclodecacyclotetradecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20-eicosahydro- | C22H40 | 76.61 | 304.3 | 94 | 13.517 | 14113-62-3 | NIST11.L |
225643 | 9-Cycloheptadecen-1-one, (Z)– | C17H30O | 74.34 | 250.2 | 81.1 | 10.409 | 542-46-1 | NIST11.L |
224112 | 12-Methyl-E,E-2,13-octadecadien-1-ol | C19H36O | 80 | 280.3 | 85 | 14.544 | 1000130-90-4 | NIST11.L |
220290 | 9,12,15-Octadecatrienoic acid, 2-(acetyloxy)-1-[(acetyloxy)methyl]ethyl ester, (Z,Z,Z)– | C25H40O6 | 67.89 | 436.3 | 117 | 13.667 | 55320-01-9 | NIST11.L |
217000 | Phenol, 2-undecyl- | C17H28O | 76.37 | 248.2 | 94.1 | 10.955 | 20056-71-7 | NIST11.L |
214629 | E,E,Z-1,3,12-Nonadecatriene-5,14-diol | C19H34O2 | 73.79 | 294.3 | 111.1 | 14.94 | 1000131-11-4 | NIST11.L |
201901 | cis-9-Hexadecenal | C16H30O | 80.37 | 238.2 | 97.1 | 11.447 | 56219-04-6 | NIST11.L |
197393 | 13-Docosenamide, (Z)– | C22H43NO | 77.49 | 337.3 | 59 | 16.48 | 112-84-5 | NIST11.L |
196079 | Caryophyllene oxide | C15H24O | 75.62 | 220.2 | 133.1 | 12.565 | 1139-30-6 | NIST11.L |
174210 | 2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | C15H24O4 | 76.87 | 268.2 | 85 | 13.469 | 108511-84-8 | NIST11.L |
173866 | 9-Octadecenoic acid (Z)-, methyl ester | C19H36O2 | 84.25 | 296.3 | 55 | 12.367 | 112-62-9 | NIST11.L |
158247 | Sclaral (sclareolide lactol) | C16H28O2 | 70.48 | 252.2 | 237.2 | 14.886 | 52811-62-8 | NIST11.L |
148648 | 2-Isoamylpyrazine | C9H14N2 | 68.98 | 150.1 | 94.1 | 12.089 | 40790-22-5 | NIST11.L |
144711 | .gamma.-Tocopherol | C28H48O2 | 66.81 | 416.4 | 151.1 | 19.047 | 7616-22-0 | NIST11.L |
130975 | p-Menth-8-en-3-ol, acetate | C12H20O2 | 71.42 | 196.1 | 121 | 12.522 | 89-49-6 | NIST11.L |
127798 | Farnesol isomer a | C15H26O | 74.05 | 222.2 | 69 | 13.014 | 1000108-92-4 | NIST11.L |
121571 | Hexadecanoic acid, methyl ester | C17H34O2 | 60.81 | 270.3 | 74 | 11.222 | 112-39-0 | NIST11.L |
119991 | Sclaral (sclareolide lactol) | C16H28O2 | 74.41 | 252.2 | 237.2 | 14.635 | 52811-62-8 | NIST11.L |
118782 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 70.73 | 282.3 | 69.1 | 16.539 | 1000130-81-0 | NIST11.L |
117278 | Oleic Acid | C18H34O2 | 71.31 | 282.3 | 55 | 11.639 | 112-80-1 | NIST11.L |
114475 | 2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | C15H24O4 | 75.39 | 268.2 | 85 | 15.608 | 108511-84-8 | NIST11.L |
104445 | 2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | C15H24O4 | 72.68 | 268.2 | 59 | 15.26 | 108511-84-8 | NIST11.L |
102635 | 12-Methyl-E,E-2,13-octadecadien-1-ol | C19H36O | 73.38 | 280.3 | 43 | 14.779 | 1000130-90-4 | NIST11.L |
97105 | 12-Methyl-E,E-2,13-octadecadien-1-ol | C19H36O | 74.25 | 280.3 | 85.1 | 15.528 | 1000130-90-4 | NIST11.L |
95395 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 69.81 | 282.3 | 57.1 | 16.758 | 1000130-81-0 | NIST11.L |
90205 | Formic acid, 3,7,11-trimethyl-1,6,10-dodecatrien-3-yl ester | C16H26O2 | 64.55 | 250.2 | 117 | 13.886 | 1000132-11-0 | NIST11.L |
83029 | 9,12-Octadecadienoic acid (Z,Z)–, methyl ester | C19H34O2 | 82.86 | 294.3 | 94 | 12.335 | 112-63-0 | NIST11.L |
81266 | Stigmastan-3,5-diene | C29H48 | 62.42 | 396.4 | 207 | 19.352 | 1000214-16-4 | NIST11.L |
80710 | 7-Methyl-Z-tetradecen-1-ol acetate | C17H32O2 | 73.25 | 268.2 | 117 | 13.843 | 1000130-99-6 | NIST11.L |
79895 | Cyclohexane, 1,5-diethenyl-2,3-dimethyl-, (1.alpha.,2.beta.,3.beta.,5.beta.)- | C12H20 | 66.11 | 164.2 | 94 | 10.693 | 68779-12-4 | NIST11.L |
79553 | Caryophyllene oxide | C15H24O | 80.12 | 220.2 | 95 | 13.174 | 1139-30-6 | NIST11.L |
75917 | Heptacosane | C27H56 | 67.85 | 380.4 | 57 | 17.475 | 593-49-7 | NIST11.L |
68591 | Phenol, 2,5-bis(1,1-dimethylethyl)- | C14H22O | 60.78 | 206.2 | 191.2 | 8.27 | 5875-45-6 | NIST11.L |
67261 | Propanoic acid, 3-mercapto-, dodecyl ester | C15H30O2S | 78.73 | 274.2 | 57.1 | 11.901 | 6380-71-8 | NIST11.L |
67173 | 2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | C15H24O4 | 77.39 | 268.2 | 85.1 | 13.42 | 108511-84-8 | NIST11.L |
63628 | 2-Bromotetradecane | C14H29Br | 72.05 | 276.1 | 71.1 | 9.543 | 74036-95-6 | NIST11.L |
62123 | 1,2-15,16-Diepoxyhexadecane | C16H30O2 | 77.92 | 254.2 | 69.1 | 13.046 | 1000192-65-0 | NIST11.L |
61775 | 1,2-15,16-Diepoxyhexadecane | C16H30O2 | 74.2 | 254.2 | 97.1 | 9.997 | 1000192-65-0 | NIST11.L |
60013 | 12-Methyl-E,E-2,13-octadecadien-1-ol | C19H36O | 81.12 | 280.3 | 95 | 14.335 | 1000130-90-4 | NIST11.L |
59523 | Heptacosane | C27H56 | 66.66 | 380.4 | 57 | 17.234 | 593-49-7 | NIST11.L |
57603 | Phosphoric acid, trimethyl ester | C3H9O4P | 87.9 | 140 | 110 | 3.279 | 512-56-1 | NIST11.L |
56870 | 7-Hexadecenal, (Z)– | C16H30O | 74.19 | 238.2 | 57.1 | 12.217 | 56797-40-1 | NIST11.L |
50564 | Heptacosane | C27H56 | 75.64 | 380.4 | 71.1 | 15.929 | 593-49-7 | NIST11.L |
49635 | 2-methyltetracosane | C25H52 | 79.82 | 352.4 | 43 | 11.04 | 1000376-72-6 | NIST11.L |
44135 | 2-methyltetracosane | C25H52 | 76.32 | 352.4 | 71.1 | 11.083 | 1000376-72-6 | NIST11.L |
42262 | 3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)- | C13H22O3 | 66.26 | 226.2 | 81 | 10.447 | 95906-83-5 | NIST11.L |
41762 | (2,2,6-Trimethyl-bicyclo[4.1.0]hept-1-yl)-methanol | C11H20O | 67.8 | 168.2 | 94 | 10.73 | 78996-11-9 | NIST11.L |
41510 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 63.75 | 282.3 | 57 | 16.341 | 1000130-81-0 | NIST11.L |
41096 | 1,2-15,16-Diepoxyhexadecane | C16H30O2 | 77.5 | 254.2 | 69 | 13.207 | 1000192-65-0 | NIST11.L |
39859 | Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)- | C15H26 | 64.69 | 206.2 | 81 | 10.27 | 54832-82-5 | NIST11.L |
33905 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 76.72 | 282.3 | 69.1 | 15.383 | 1000130-81-0 | NIST11.L |
31812 | 2-Bromotetradecane | C14H29Br | 64.58 | 276.1 | 71.1 | 9.874 | 74036-95-6 | NIST11.L |
29097 | 11,13-Dimethyl-12-tetradecen-1-ol acetate | C18H34O2 | 71.69 | 282.3 | 57 | 18.662 | 1000130-81-0 | NIST11.L |
*Notes for Tables 1-7: RT: Retention times (minutes); PA: peak area (%). GC–MS analysis was carried for the Hexane: ethanoic (1:1) extracts applying Agilent Technologies (G3440B, USA). The components of plant extract were characterized by computer simulations in commercial libraries of Wiley and NIST (National Institute of Standards and Technology). The CAS number is a database index to identifying a given chemical GSO: Grape (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate( Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts |
Table 6: Results of the GC-MS analysis of the Avocado Seed Extract (AVSO).
Compounds | Chemical (PubChem CID:) | GC MS SPECTRA(Chromatogram) |
9-Octadecenamide, (Z)- Or Oleamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO) | Compound CID: 5283387 MF: C18H35NO MW: 281.5g/mol InChIKey: FATBGEAMYMYZAF-KTKRTIGZSA-N IUPAC Name: (Z)-octadec-9-enamide Create Date: 2005-03-27 | |
Stigmastan-3,5-diene Present in (GSO, PSO, AWSO, PGSO, AVSO) | Compound CID: 525918 MF: C29H48 MW: 396.7g/mol InChIKey: ICCTZARHLGPHMT-UHFFFAOYSA-N IUPAC Name: 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl- 2,7,8,9,11,12,14,15,16,17-decahydro-1H- cyclopenta[a]phenanthrene Create Date: 2005-03-27 | |
Hexadecanamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 69421 MF: C16H33NO MW: 255.44g/mol InChIKey: HSEMFIZWXHQJAE-UHFFFAOYSA-N IUPAC Name: hexadecanamide Create Date: 2005-03-26 | |
Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters Present in GSO, PSO , PGSO | Compound CID: 605777 MF: C19H30O3 MW: 306.4g/mol InChIKey: ZUILXYOZKNAZSJ-UHFFFAOYSA-N IUPAC Name: (2,4-ditert-butylphenyl) 5-hydroxypentanoate Create Date: 2005-03-27 | |
Methyl stearate GSO, PSO ONLY | Compound CID: 8201 MF: C19H38O2 MW: 298.5g/mol InChIKey: HPEUJPJOZXNMSJ-UHFFFAOYSA-N IUPAC Name: methyl octadecanoate Create Date: 2005-03-26 | |
4-Methyl-2,4-bis(4′-trimethylsilyloxyphenyl)pentene-1 Present in GSO, PSO, ONLY | Compound CID: 610040 MF: C24H36O2Si2 MW: 412.7g/mol InChIKey: YCRIXHKHAODKFH-UHFFFAOYSA-N IUPAC Name: trimethyl-[4-[2-methyl-4-(4- trimethylsilyloxyphenyl)pent-4-en-2- yl]phenoxy]silane Create Date: 2005-03-27 | |
1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)- Present in GSO, PSO ,ONLY | Compound CID: 91715040 MF: C22H18O5 MW: 362.4g/mol InChIKey: YKAUQBZMUPNUKE-UHFFFAOYSA-N IUPAC Name: [3-(4-methylbenzoyl)oxyphenyl] 2-methoxybenzoate Create Date: 2015-04-28 | |
2-Bromotetradecane GSO, AVSO ONLY | Compound CID: 12798926 MF: C14H29Br MW: 277.28g/mol InChIKey: WZGQIDWFBFDMLE-UHFFFAOYSA-N IUPAC Name: 2-bromotetradecane Create Date: 2007-02-08 | |
Cyclotrisiloxane, hexamethyl- Present in GSO, PSO ,ONLY | Compound CID: 10914 MF: C6H18O3Si3 MW: 222.46g/mol InChIKey: HTDJPCNNEPUOOQ-UHFFFAOYSA-N IUPAC Name: 2,2,4,4,6,6-hexamethyl-1,3,5,2,4,6-trioxatrisilinane Create Date: 2005-03-27 | |
Isooctyl 3-mercaptopropionate GSO ONLY | Compound CID: 104386 MF: C11H22O2S MW: 218.36g/mol InChIKey: ZHUWXKIPGGZNJW-UHFFFAOYSA-N IUPAC Name: 6-methylheptyl 3-sulfanylpropanoate Create Date: 2005-03-26 | |
Squalene Present in( PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 638072 MF: C30H50 MW: 410.7g/mol InChIKey: YYGNTYWPHWGJRM-AAJYLUCBSA-N IUPAC Name: (6E,10E,14E,18E)-2,6,10,15,19,23- hexamethyltetracosa-2,6,10,14,18,22-hexaene Create Date: 2004-09-16 | |
Propanoic acid, 3-mercapto-, dodecyl ester Present in GSO, AVSO | Compound CID: 80796 MF: C15H30O2S MW: 274.5g/mol InChIKey: ARNIBHATWCFIIK-UHFFFAOYSA-N IUPAC Name: dodecyl 3-sulfanylpropanoate Create Date: 2005-03-26 | |
1,2-15,16-Diepoxyhexadecane | Compound CID: 543423 MF: C16H30O2 MW: 254.41g/mol InChIKey: KHOGZDMZNQXOFX-UHFFFAOYSA-N IUPAC Name: 2-[12-(oxiran-2-yl)dodecyl]oxirane Create Date: 2005-03-27 | |
cis-Vaccenic acid ASO ONLY | Compound CID: 5282761 MF: C18H34O2 MW: 282.5g/mol InChIKey: UWHZIFQPPBDJPM-FPLPWBNLSA-N IUPAC Name: (Z)-octadec-11-enoic acid Create Date: 2004-09-16 | |
cis-11-Eicosenamide Present in (ASO, AWSO, PGSO, AVSO | Compound CID: 5365374 MF: C20H39NO MW: 309.5g/mol InChIKey: LBHQTVBKPMHICN-KTKRTIGZSA-N IUPAC Name: (Z)-icos-11-enamide Create Date: 2005-03-27 | |
2-Furancarboxaldehyde, 5-methyl- Present in (ASO)only | Compound CID: 12097 MF: C6H6O2 MW: 110.11g/mol InChIKey: OUDFNZMQXZILJD-UHFFFAOYSA-N IUPAC Name: 5-methylfuran-2-carbaldehyde Create Date: 2005-03-27 | |
dl-.alpha.-Tocopherol Present in (ASO, AVSO) | Compound CID: 2116 MF: C29H50O2 MW: 430.7g/mol InChIKey: GVJHHUAWPYXKBD-UHFFFAOYSA-N IUPAC Name: 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)- 3,4-dihydrochromen-6-ol Create Date: 2005-03-25 | |
4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- Present in (ASO, AWSO) | Compound CID: 119838 MF: C6H8O4 MW: 144.12g/mol InChIKey: VOLMSPGWNYJHQQ-UHFFFAOYSA-N IUPAC Name: 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one Create Date: 2005-03-27 | |
5-Hydroxymethylfurfural Present in (AWSO) | Compound CID: 237332 MF: C6H6O3 MW: 126.11g/mol InChIKey: NOEGNKMFWQHSLB-UHFFFAOYSA-N IUPAC Name: 5-(hydroxymethyl)furan-2-carbaldehyde Create Date: 2005-03-26 | |
Oleic Acid Present in AWSO, AVSO | Compound CID: 445639 MF: C18H34O2 MW: 282.5g/mol InChIKey: ZQPPMHVWECSIRJ-KTKRTIGZSA-N IUPAC Name: (Z)-octadec-9-enoic acid Create Date: 2004-09-16 | |
.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl Present in AWSO | Compound CID: 220003 MF: C18H32O16 MW: 504.4g/mol InChIKey: QWIZNVHXZXRPDR-UHFFFAOYSA-N IUPAC Name: 2-[4-hydroxy-2,5-bis(hydroxymethyl)-2-[3,4,5- trihydroxy-6-(hydroxymethyl)oxan-2- yl]oxyoxolan-3-yl]oxy-6-(hydroxymethyl)oxane- 3,4,5-triol Create Date: 2005-03-26 | |
Palmitic Acid Present in AWSO | Compound CID: 985 MF: C16H32O2 MW: 256.42g/mol InChIKey: IPCSVZSSVZVIGE-UHFFFAOYSA-N IUPAC Name: hexadecanoic acid Create Date: 2004-09-16 | |
Levoglucosenone Present in AWSO | Compound CID: 699486 MF: C6H6O3 MW: 126.11g/mol InChIKey: HITOXZPZGPXYHY-UJURSFKZSA-N IUPAC Name: (1S,5R)-6,8-dioxabicyclo[3.2.1]oct-2-en-4-one Create Date: 2004-09-16 | |
Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester Present in AWSO | Compound CID: 566079 MF: C9H14O3 MW: 170.21g/mol InChIKey: ZFZXRNVTYVRULM-UHFFFAOYSA-N IUPAC Name: ethyl 3-formyl-2,2-dimethylcyclopropane-1- carboxylate Create Date: 2005-03-27 | |
1H-Inden-1-ol, 2,3-dihydro- Present in AWSO | Compound CID: 22819 MF: C9H10O MW: 134.17g/mol InChIKey: YIAPLDFPUUJILH-UHFFFAOYSA-N IUPAC Name: 2,3-dihydro-1H-inden-1-ol Create Date: 2004-09-16 | |
Phenol, 2,6-bis(1,1-dimethylethyl)- Present in AWSO | Compound CID: 31405 MF: C14H22O MW: 206.32g/mol InChIKey: DKCPKDPYUFEZCP-UHFFFAOYSA-N IUPAC Name: 2,6-ditert-butylphenol Create Date: 2005-03-26 | |
Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester Present in AWSO | Compound CID: 545402 MF: C9H15ClO3 MW: 206.66g/mol InChIKey: SZVRMPXPAYKBKB-UHFFFAOYSA-N IUPAC Name: tert-butyl 2-chloro-2-(2-methyloxiran-2- yl)acetate Create Date: 2005-03-27 | |
Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro- | Compound CID: 5377998 MF: C20H36 MW: 276.5g/mol InChIKey: YNIDDVZQMSOPPE-VXPUYCOJSA-N IUPAC Name: (1Z)-bicyclo[10.8.0]icos-1(12)-ene Create Date: 2005-03-27 | |
2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro- | Compound CID: 543312 MF: C22H40O2 MW: 336.6g/mol InChIKey: ONANHJGDQJCYMD-UHFFFAOYSA-N IUPAC Name: 2-heptadec-7-ynoxyoxane Create Date: 2005-03-27 | |
Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)- | Compound CID: 14681481 MF: C21H34O2 MW: 318.5g/mol InChIKey: SPKGPDRGORWGNP-SISSWOJJSA-N IUPAC Name: (5S,8R,9S,10S,13S,14S)-3-ethyl-3-hydroxy-10,13- dimethyl-2,4,5,6,7,8,9,11,12,14,15,16- dodecahydro-1H-cyclopenta[a]phenanthren-17- one Create Date: 2007-02-09 | |
Z,E-2,13-Octadecadien-1-ol | Compound CID: 5364462 MF: C18H34O MW: 266.5g/mol InChIKey: YCOMGIOWVNOOBC-YZDAJDCNSA-N IUPAC Name: (2Z,13E)-octadeca-2,13-dien-1-ol Create Date: 2005-03-27 | |
Chrysene, octadecahydro | Compound CID: 98460 MF: C18H30 MW: 246.4g/mol InChIKey: ZEMKTMFBYLHVNN-UHFFFAOYSA-N IUPAC Name: 1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10a,10b,11,12,12a- octadecahydrochrysene Create Date: 2005-03-26 | |
Bicyclo[10.6.0]octadeca-1(12),15-diene | Compound CID: 5362802 MF: C18H30 MW: 246.4g/mol InChIKey: VZCXNHIRQUVFRT-GROAESOISA-N IUPAC Name: (1Z,15Z)-bicyclo[10.6.0]octadeca-1(12),15-diene Create Date: 2005-03-27 | |
3-Chloropropionic acid, heptadecyl ester | Compound CID: 545757 MF: C20H39ClO2 MW: 347g/mol InChIKey: UDESWCQJPWPMKY-UHFFFAOYSA-N IUPAC Name: heptadecyl 3-chloropropanoate Create Date: 2005-03-27 | |
1-Heptatriacotanol | Compound CID: 537071 MF: C37H76O MW: 537g/mol InChIKey: ZGJKNMPTVDDRRH-UHFFFAOYSA-N IUPAC Name: heptatriacontan-1-ol Create Date: 2005-03-27 | |
13-Docosenamide, (Z)- | Compound CID: 5365371 MF: C22H43NO MW: 337.6g/mol InChIKey: UAUDZVJPLUQNMU-KTKRTIGZSA-N IUPAC Name: (Z)-docos-13-enamide Create Date: 2005-03-27 | |
Caryophyllene oxide | Compound CID: 1742210 MF: C15H24O MW: 220.35g/mol InChIKey: NVEQFIOZRFFVFW-RGCMKSIDSA-N IUPAC Name: (1R,4R,6R,10S)-4,12,12-trimethyl-9-methylidene- 5-oxatricyclo[8.2.0.04,6]dodecane Create Date: 2005-07-12 | |
Heptacosane | Compound CID: 11636 MF: C27H56 MW: 380.7g/mol InChIKey: BJQWYEJQWHSSCJ-UHFFFAOYSA-N IUPAC Name: heptacosane Create Date: 2004-09-16 | |
.gamma.-Tocophero | Compound CID: 91738518 MF: C30H47F3O3 MW: 512.7g/mol InChIKey: OWMUJRCXUOSNAV-UHFFFAOYSA-N IUPAC Name: [2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-3,4- dihydrochromen-6-yl] 2,2,2-trifluoroacetate Create Date: 2015-04-28 | |
p-Menth-8-en-3-ol, acetate | Compound CID: 94579 MF: C12H20O2 MW: 196.29g/mol InChIKey: HLHIVJRLODSUCI-ADEWGFFLSA-N IUPAC Name: [(1R,2S,5R)-5-methyl-2-prop-1-en-2- ylcyclohexyl] acetate Create Date: 2005-03-26 | |
Sclaral (sclareolide lactol) | Compound CID: 537618 MF: C16H28O2 MW: 252.39g/mol InChIKey: UZSSRRVZGDVPRE-UHFFFAOYSA-N IUPAC Name: 3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b- octahydro-1H-benzo[e][1]benzofuran-2-ol Create Date: 2005-03-27 | |
12-Methyl-E,E-2,13-octadecadien-1-ol | Compound CID: 90107969 MF: C19H36O MW: 280.5g/mol InChIKey: QQRKGLQLQDQGQI-WSGPNKEYSA-N IUPAC Name: (2E,13E)-12-methyloctadeca-2,13-dien-1-ol Create Date: 2015-02-13 | |
Phenol, 2,5-bis(1,1-dimethylethyl)- | Compound CID: 79983 MF: C14H22O MW: 206.32g/mol InChIKey: KDBZVULQVCUNNA-UHFFFAOYSA-N IUPAC Name: 2,5-ditert-butylphenol Create Date: 2005-03-26 | |
2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | Compound CID: 538309 MF: C15H24O4 MW: 268.35g/mol InChIKey: GNQFBOZHHSYHCB-UHFFFAOYSA-N IUPAC Name: (2,2,6-trimethyl-9,10- dioxatricyclo[6.2.2.01,6]dodecan-3-yl) acetate Create Date: 2005-03-27 | |
3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)- | Compound CID: 606210 MF: C13H22O3 MW: 226.31g/mol InChIKey: RBFWHMUVCHUYON-UHFFFAOYSA-N IUPAC Name: 5,5-dimethyl-11,12- dioxatricyclo[8.2.1.01,6]tridecan-10-ol Create Date: 2005-03-27 | |
Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)- | Compound CID: 549738 MF: C15H26 MW: 206.37g/mol InChIKey: PUJIBQKSZBPAMT-UHFFFAOYSA-N IUPAC Name: 2,2,5,5,8,8-hexamethyltricyclo[4.3.0.07,9]nonane Create Date: 2005-03-27 | |
GSO: Grape (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado ( Persea Americana) extracts. |
Table 7: Results of the GC-MS chromatogram of the selected compounds in studied seeds (GSO, PSO, ASO, AWSO, PGSO and AVSO).
Docking Protein (Epinephrine Receptor PDB: 2rh1) with the Ligand (Seeds GSO, PSO, ASO, AWSO, PGSO and AVSO) Phytochemical Molecule and the ACE2 Receptor
The epinephrine receptor PDB: 2rh1 and ACE2 receptor 3D0G (Table 8) showed binding energy with the six studied seeds in the current study’s oils extracts 44 ligands (Table 9). Table 9 reflects the binding affinity of 44 ligands to both investigated receptors. These docking studies showed that among the seed extract phytochemicals, the stigmastan-3,5-diene (compound CID: 525918, MF: C29H48) component of GSO, PSO, AWSO, PGSO and AVSO had the highest binding affinity of -11.4 kcal/mole and -11.6 kcal/mole, with 2rh1 and 3D0G, respectively. Moreover, the levoglucosenone (compound CID: 699486, MF: C6H6O3) component of AWSO extract had the lowest binding affinity at -4.8 kcal/mole and 5.5 kcal/mole with 2rh1 and 3D0G, respectively, as given in Table 10. The ligands with the best possible affinity to the receptor 2rh1 and ACE2 receptor 3D0G are outlined in Table 10, while the comparison of the highest binding energy is provided in Fig. 2.
Figure 2: Comparison between the highest binding affinity (kcal/mole) interaction of 44 ligands of GSO, PSO, ASO, AWSO, PGSO and AVSO with the β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) in the AutoDock analysis. (GSO: Grapes (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts).
Target | Target protein receptor (PDB) |
1-Epinephrine (adrenaline) To potential antistress | β2 adrenoreceptor (PDB: 2rh1)
3D structure of 2rh1 Deposition author(s): Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G.F., Thian, F.S., Kobilka, T.S., Choi, H.J., Kuhn, P., Weis, W.I., Kobilka, B.K., Stevens, R.C., Accelerated Technologies Center for Gene to 3D Structure (ATCG3D), GPCR Network (GPCR). |
2-Angiotensin-converting enzyme 2 The ACE2 receptor The SARS-CoV-2 virus requires ACE2 to infect cells to potential new clinical trial tests ACE inhibitor against SARS-CoV-2 | 3D0G
-Deposition Author(s): Li, F. 3D structure of 3D0G |
Table 8: The target receptors used in AutoDock analysis.
Compounds separated by GC–MS | Chemical (PubChem CID:) | AutoDock analysis results with 2rh1 | AutoDock analysis results with 3D0G |
9-Octadecenamide, (Z)- Or Oleamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO) | Compound CID: 5283387
| ||
Stigmastan-3,5-diene Present in (GSO, PSO, AWSO, PGSO, AVSO) | Compound CID: 525918
| ||
Hexadecanamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 69421
| ||
Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters Present in GSO, PSO , PGSO | Compound CID: 605777
| ||
Methyl stearate GSO, PSO ONLY | Compound CID: 8201
| ||
1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)- Present in GSO, PSO, ONLY | Compound CID: 91715040
| ||
2-Bromotetradecane GSO, AVSO ONLY | Compound CID: 12798926
| ||
Isooctyl 3-mercaptopropionate GSO ONLY | Compound CID: 104386
| ||
Squalene Present in( PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 638072
| ||
Propanoic acid, 3-mercapto-, dodecyl ester Present in GSO, AVSO | Compound CID: 80796
| ||
1,2-15,16-Diepoxyhexadecane | Compound CID: 543423
| ||
cis-Vaccenic acid ASO ONLY | Compound CID: 5282761
| ||
cis-11-Eicosenamide Present in (ASO, AWSO, PGSO, AVSO | Compound CID: 5365374
| ||
2-Furancarboxaldehyde, 5-methyl- Present in (ASO)only | Compound CID: 12097
| ||
dl-.alpha.-Tocopherol Present in (ASO, AVSO) | Compound CID: 2116
| ||
4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- Present in (ASO, AWSO) | Compound CID: 119838
| ||
5-Hydroxymethylfurfural Present in (AWSO) | Compound CID: 237332
| ||
Oleic Acid Present in AWSO, AVSO | Compound CID: 445639
| ||
.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl Present in AWSO | Compound CID: 220003
| ||
Palmitic Acid Present in AWSO | Compound CID: 985
| ||
Levoglucosenone Present in AWSO | Compound CID: 699486
| ||
Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester Present in AWSO | Compound CID: 566079
| ||
1H-Inden-1-ol, 2,3-dihydro- Present in AWSO | Compound CID: 22819
| ||
Phenol, 2,6-bis(1,1-dimethylethyl)- Present in AWSO | Compound CID: 31405 | ||
Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester Present in AWSO | Compound CID: 545402
| ||
Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro- Present in AVSO | Compound CID: 5377998
| ||
2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro- Present in AVSO | Compound CID: 543312
| ||
Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)- Present in AVSO | Compound CID: 14681481
| ||
Z,E-2,13-Octadecadien-1-ol Present in AVSO | Compound CID: 5364462
| ||
Chrysene, octadecahydro Present in AVSO | Compound CID: 98460
| ||
Bicyclo[10.6.0]octadeca-1(12),15-diene Present in AVSO | Compound CID: 5362802
| ||
3-Chloropropionic acid, heptadecyl ester Present in AVSO | Compound CID: 545757
| ||
1-Heptatriacotanol Present in AVSO | Compound CID: 537071
| ||
13-Docosenamide, (Z)- Present in AVSO | Compound CID: 5365371
| ||
Caryophyllene oxide Present in AVSO | Compound CID: 1742210
| ||
Heptacosane Present in AVSO | Compound CID: 11636
| ||
.gamma.-Tocophero Present in AVSO | Compound CID: 91738518
| ||
p-Menth-8-en-3-ol, acetate Present in AVSO | Compound CID: 94579
| ||
Sclaral (sclareolide lactol) Present in AVSO | Compound CID: 537618
| ||
12-Methyl-E,E-2,13-octadecadien-1-ol Present in AVSO | Compound CID: 90107969
| ||
Phenol, 2,5-bis(1,1-dimethylethyl)- Present in AVSO | Compound CID: 79983
| ||
2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin Present in AVSO | Compound CID: 538309
| ||
3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)- Present in AVSO | Compound CID: 606210
| ||
Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)- Present in AVSO | Compound CID: 549738
|
Table 9: Results of the GC-MS analysis of the studied seed extracts (GSO, PSO, ASO, AWSO, PGSO and AVSO) with the AutoDock analysis as potential ligand binding to the β2 adrenoceptor (2rh1) and ACE2 receptor (3D0G).
Compounds | Chemical (PubChem CID) | Global binding energy of the highest binding affinity (kcal/mole) with 2rh1 with the best enlarged angle for ligand with the protein
| Global binding energy of the highest binding affinity (kcal/mole) with3D0G with the best enlarged angle for ligand with the protein |
9-Octadecenamide, (Z)- Or Oleamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO) | Compound CID: 5283387 MF: C18H35NO | -7.9 | -8.7
|
Stigmastan-3,5-diene Present in (GSO, PSO, AWSO, PGSO, AVSO) | Compound CID: 525918 MF: C29H48 | -11.4 | -11.6 |
Hexadecanamide Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 69421 MF: C16H33NO | -6.6 | -7.7 |
Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters Present in GSO, PSO, PGSO | Compound CID: 605777 MF: C19H30O3 | -10.2 | -10.1 |
Methyl stearate GSO, PSO ONLY | Compound CID: 8201 MF: C19H38O2 | -6.0 | -5.7 |
1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)- Present in GSO, PSO ,ONLY | Compound CID: 91715040 MF: C22H18O5 | -10.3 | -9.5 |
2-Bromotetradecane GSO, AVSO ONLY | Compound CID: 12798926 MF: C14H29Br | -5.4 | -6.1 |
Isooctyl 3-mercaptopropionate GSO ONLY | Compound CID: 104386 MF: C11H22O2S | -6.4 | -7.2 |
Squalene Present in( PSO, ASO, AWSO, PGSO, AVSO | Compound CID: 638072 MF: C30H50 | -10.6 | -9.7 |
Propanoic acid, 3-mercapto-, dodecyl ester Present in GSO, AVSO | Compound CID: 80796 MF: C15H30O2S | -6.7 | -6.5 |
1,2-15,16-Diepoxyhexadecane | Compound CID: 543423 MF: C16H30O2 | -5.8 | -6.3 |
cis-Vaccenic acid ASO ONLY | Compound CID: 5282761 MF: C18H34O2 | -8.2 | -9.3 |
cis-11-Eicosenamide Present in (ASO, AWSO, PGSO, AVSO | Compound CID: 5365374 MF: C20H39NO | -7.5 | -7.5 |
2-Furancarboxaldehyde, 5-methyl- Present in (ASO)only | Compound CID: 12097 MF: C6H6O2 | -5.2 | -5.5 |
dl-.alpha.-Tocopherol Present in (ASO, AVSO) | Compound CID: 2116 MF: C29H50O2 | -10.2 | -9.2 |
4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- Present in (ASO, AWSO) | Compound CID: 119838 MF: C6H8O4 | -5.5 | -5.5 |
5-Hydroxymethylfurfural Present in (AWSO) | Compound CID: 237332 MF: C6H6O3 | -5.2 | -5.8 |
Oleic Acid Present in AWSO, AVSO | Compound CID: 445639 MF: C18H34O2 | -6.9 | -7.5 |
.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl Present in AWSO | Compound CID: 220003 MF: C18H32O16 | -9.0 | -9.2 |
Palmitic Acid Present in AWSO | Compound CID: 985 MF: C16H32O2 | -6.2 | -6.8 |
Levoglucosenone Present in AWSO | Compound CID: 699486 MF: C6H6O3 | -4.8 | -5.5 |
Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester Present in AWSO | Compound CID: 566079 MF: C9H14O3 | -5.5 | -5.9 |
1H-Inden-1-ol, 2,3-dihydro- Present in AWSO | Compound CID: 22819 MF: C9H10O | -6.4 | -8.1 |
Phenol, 2,6-bis(1,1-dimethylethyl)- Present in AWSO | Compound CID: 31405 MF: C14H22O | -7.5 | -9.2 |
Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester Present in AWSO | Compound CID: 545402 MF: C9H15ClO3 | -6.1 | -6.6 |
Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro- | Compound CID: 5377998 MF: C20H36 | -10.2 | -10.9 |
2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro- | Compound CID: 543312 MF: C22H40O2 | -6.6 | -6.2 |
Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)- | Compound CID: 14681481 MF: C21H34O2 | -10.7 | -11.5 |
Z,E-2,13-Octadecadien-1-ol | Compound CID: 5364462 MF: C18H34O | -6.7 | -6.9 |
Chrysene, octadecahydro | Compound CID: 98460 MF: C18H30 | -9.6 | -11.5 |
Bicyclo[10.6.0]octadeca-1(12),15-diene | Compound CID: 5362802 MF: C18H30 | -9.2 | -10.6 |
3-Chloropropionic acid, heptadecyl ester | Compound CID: 545757 MF: C20H39ClO2 | -7.4 | -6.8 |
1-Heptatriacotanol | Compound CID: 537071 | -5.3 | -4.6 |
13-Docosenamide, (Z)- | Compound CID: 5365371 MF: C22H43NO | -8.8 | -8.6 |
Caryophyllene oxide | Compound CID: 1742210 MF: C15H24O | -8.6 | -10.4 |
Heptacosane | Compound CID: 11636 MF: C27H56 | -5.9 | -5.0 |
.gamma.-Tocophero | Compound CID: 91738518 MF: C30H47F3O3 | -10.0 | -8.8 |
p-Menth-8-en-3-ol, acetate | Compound CID: 94579 MF: C12H20O2 | -7.7 | -9.0 |
Sclaral (sclareolide lactol) | Compound CID: 537618 MF: C16H28O2 | -9.2 | -9.7 |
12-Methyl-E,E-2,13-octadecadien-1-ol | Compound CID: 90107969 MF: C19H36O | -6.4 | -7.0 |
Phenol, 2,5-bis(1,1-dimethylethyl)- | Compound CID: 79983 | -7.8 | -9.1 |
2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin | Compound CID: 538309 MF: C15H24O4 | -8.7 | -10.9 |
3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)- | Compound CID: 606210 MF: C13H22O3 | -8.2 | -10.4 |
Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)- | Compound CID: 549738 MF: C15H26 | -8.8 | -10.8 |
Synergetic | Mean =7.66 | Mean =-8.35 |
Table 10: Prediction of the best interaction of the ligands of GSO, PSO, ASO, AWSO, PGSO and AVSO with β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) in the AutoDock analysis.
Discussion
The coronavirus pandemic has had many consequences, including health, psychological and economic consequences. The World Health Organization approved a group of drugs to treat the virus. Besides the drugs, there are ongoing races in production of vaccines. Furthermore, scientists are increasingly focusing their efforts to discover vaccines without side effects. However, the discovery of novel coronavirus mutations requires more attention and considerations and varied drugs and vaccine proposals; for example, phytochemistry potential trials.
Phytochemicals in fruits, vegetables and plant parts hold secondary metabolites and their essential metabolites have several inherent biological activities that involve antimicrobial, anti-inflammatory and inhibitory enzyme properties with health benefits [30,31]. In our previous studies, avocado and pomegranate juice, peel and seed oil ameliorated toxicity and decreased inflammation, oxidative stress and apoptosis induced by CCl4 and DEN [21,32-35].
Grape (Vitis vinifera) was introduced to the literature as a treatment after an arb doctor suggested it as a royal oil for skin treatment for Ferdinand IV in the 14th century. It also has antioxidant and anti-inflammatory properties, according to the previous investigation. The seed composition of fruits depends on maturation, the environmental cultivation state and extraction protocol [36-38]. The results of the current study’s seed extract analysis (Table 1-7) showed that Grape Seed Oil (GSO) included 9-octadecenamide, (z)-, stigmastan-3, 5-diene, 9, 12-octadecadienoic acid (z, z)-, methyl ester, oleamide, hexadecanamide and phosphoric acid trimethyl ester. Furthermore, GSO was found to contain dodecyl acrylate, pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters, methyl stearate and 1-pentadecyne. It also included 1-pentadecyne, 11, 13-dimethyl-12-tetradecen-1-ol acetate, 4-methyl-2,4-bis(4′-trimethylsilyloxyphenyl)pentene-1, 1,3-benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-, 2-bromotetradecane, cyclotrisiloxane, hexamethyl- and isooctyl 3-mercaptopropionate (Table 1).
GSO compositions such as 9-octadecenamide, (z)-, 9,12-octadecadienoic acid (z, z)-, oleamide and hexadecanamide have a sedative effect where a group of an amide of the fatty acid oleic acid is located as naturally endogenous on the animal’s body. It has an accumulation function in the cerebrospinal fluid during sleep deprivation and influences animal’s sleep, making those oleamide derivatives potential treatments for mood, depression and sleep disorders through interaction with multiple neurotransmitters. Further, it binds the Cannabinoid receptor type 1 (CB1) receptor as a full agonist. Also, these derivatives have anti-corrosive properties [39-42]. Stigmastane, 24R-ethylcholestane, is a tetracyclic triterpene and cholestane as well as ergostane. This sterane is applied as a biomarker for initial eukaryotes. Stigmastanol, Stigmastan-3, 5-diene and their derivatives are types of plant phytosterol that inhibit cholesterol absorption from the diet [43]. Acrylates are the salts, esters and conjugate bases of acrylic acid, including dodecyl acrylate, for example. They have various bifunctional functionalities such as in the polymers industry and as antimicrobial and non-chemical based antioxidant agents [44-46]. GSO also contains phosphoric acids that are not genotoxic nor carcinogenic and is therefore used as a food additive in water treatment products. Further, it is used as phosphate salts for fertilizers, dental cement, albumin derivatives and the sugar and textile industries [47].
GSO contains a group of ester, acetate and valeric or pentanoic acids; all have pleasant odors and are used in the perfume and cosmetic additives industry. Valeric acid is a minor product of the gut microbiome and can also be produced by its esters’ metabolism found in food [48,49]. The repair of these acid levels in the gut has been recommended as the mechanism in the govern of the clostridioides difficile infection after fecal microbiota transplant [49].
Methyl stearate is a fatty acid methyl ester and octadecanoate ester. Stearic acid has a role as a metabolite and is connected with reduced LDL cholesterol compared to other saturated fatty acids. It is used in lubricants, detergents, softening agents, release agents and food additives, as well as in batteries and electronic devices [50,51].
GSO contains different bioactive secondary metabolites such as sulfurous acid, 2-ethylhexyl isohexyl ester, heptacosane, dodecyl pentyl ester, eicosane 2- methyl, benzyl detervitive and 2-bromotetradecane, dodecyl acrylate as well as 1,3-benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-. These combinations of secondary metabolites are related to antibacterial, antifungal and anti-diabetic attributes [52-55]. Other metabolites such as 4-methyl-2, 4-bis (4-hydroxyphenyl) pent-1-ene (MBP) have potent estrogenic action in-vitro and in-vivo; moreover, computer modelling has revealed that this greater strength is due to more effective binding to estrogen receptors. Previous studies reported that cyclotrisiloxane and hexamethyl- derivatives have antioxidant and antibacterial activity. GSO contains isooctyl 3-mercaptopropionate that depravities reported antioxidant and anti-inflammatory [56-59].
A plum is a fruit of a unique species, Prunus subg. Prunus. Plum stones include a seed with a high content of proteins and lipids that are frequently underused and undervalued. Victoria Plum Seed Oil extract (PSO) includes phytosterols such as stigmastan-3, 5-diene and hexadecanamide derivatives also found in current grape seed extract (Table 2). PSO contains esters, methyl stearate, dodecyl acrylate and benzyl detectives, which have beneficial antibacterial, anti-inflammatory, anticancer and antioxidant effects, as was discussed before concerning grape seed oil extract with the relative value of RT: Retention Times (minutes). PSO comprises squalene, a natural organic polyunsaturated hydrocarbon of the triterpene type know as shark liver oil. All plants, animals, birds and human livers provide squalene as a biochemical intermediate. It preserves polyunsaturated fatty acids against temperature-dependent autoxidation. Squalene also functions essentially as a peroxyl radical scavenger, is useful for skin hydration, works as an antioxidant, has antitumor properties and is used in cosmetics [60,61].
Apple seeds are rich in proteins, carbohydrates and minerals, making them useful as feed or fertilizer [62]. Moreover, they contain fatty linoleic acid, sterols, tocopherols, a primary fatty amid cis-11-eicosenamide and hydrocarbons, especially squalene 63, which is confirmed by the present study’s apple seed oil GC-MS analysis. Previous investigations reported that apple seed oil can improve the treatment of various diseases, especially Cardiovascular Disease (CVD) and diabetic disorder. This improvement is effected by managing the blood lipid profile, blood pressure, adipocyte hormones, inflammatory response, endothelial capacity and through numerous other beneficial effects as anticancer, antioxidant and antibacterial properties [64,65]. Moreover, dl-.alpha.-tocopherol (vitamin E) was reported as an antidepressant and significant antioxidant [63-65]. Apple Seed Oil (ASO) contains hexadecanamide, benzoic acid fatty acid esters and -octadecenoic acid and their derivatives, which have beneficial antibacterial, anti-inflammatory, anticancer and antioxidant effects, as discussed before regarding grape seed oil and plum seed oil. Apple seeds oil, also rich in fatty acids such as vaccenic acid, is an omega-7 fatty acid with antibacterial, antioxidant and anti-coronary heart disease properties [66,67]. ASO includes 2-pyrrolidinovalerophenone, which is used as a bath salt and has a neurological effect and 2-furancarboxaldehyde, 5-methyl-F, which is a derivative inhibiting sickle cell formation in the blood.
Additionally, it contains radical scavenging activity compounds such as 13-Tetradecenal. This is because plum, grape and apple seeds have a phenolic composition with antioxidant capacity, comprising 4H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- and 9,12-octadecadienoic acid (Z, Z)- and phenylmethyl ester [68-71].
Date palm (Phoenixdactylifera) is a member of the palm family (Arecaceae) and has been used as food for over 6000 years. It is found in Saudi Arabia, Middle Eastern countries and Egypt. Its components such as carbohydrates, phytochemicals, sterols, carotenes and flavonoids have been screened for numerous therapeutic activities and are found to decrease the side effects of manufactured medicines that hurt the human biological system. Besides, date seeds are used as animal feed or caffeine-free coffee replacements in some areas. The Ajwa date seed oil includes sterol, phytochemistry, oleic, palmitic and fatty acids and their derivatives; these have antibacterial, antioxidant, anticancer and antilipidemic effects [72,73]. The present work reported that Ajwa date seed oil (AWSO) contains hexadecanamide, 5-hydroxymethylfurfura, 9-octadecenamide, (Z)-, oleic acid, cis-11-eicosenamide, dodecanoic acid and palmitic acid. Squalene and stigmastan-3,5-diene are found in it. AWSO contains fatty acid ester, other phenol and furfural derivatives, as presented in Table 4. These compounds have antioxidant and anti-inflammatory, neurological, sedation and cosmetic effects. Moreover, it contains 7-methyl-Z-tetradecen-1-of acetate, which has the effect of heat and heat cough [74].
The present work reported that pomegranate (Punica granatum L.), which belongs to the Punicaceae famil (PGSO), contains hexadecanamide, 5-hydroxymethylfurfural, 9-octadecenamide, (Z)-, oleamide, cis-11-eicosenamide, dodecyl acrylate and fatty acid ester, as well as phenol, squalene, stigmastan-3,5-diene (Table 5). These compounds have antioxidant and anti-inflammatory effects [19]. Avocados (Percea Americana) are related to the Lauraceae family. Avocados contain carotenoids, minerals, phenolics, vitamins and fatty acids. Further, avocados have lipid-lowering, antihypertensive, antidiabetic, anti-obesity, antithrombotic, antiapoptosis and anti-atherosclerotic cardio-protective effects. The avocado seeds are considered one of the fruit’s non-edible parts, which are generally discarded as trash and can cause environmental problems. Examining such foods’ underutilized dietary and therapeutic potential will also diminish the environmental waste load [33,75].
The composition of avocado seed includes protein, fat, ash, moisture, fiber and carbohydrate, minerals such as Ca, Zn, K, Na, P, Fe, Cu, Pb and Co) phytochemicals (flavinoid, tanine, saponine, total phenolics, antioxidant capacity, oxalates, phytates and alkaloids) and vitamins (A, B1, B2, B3, C and E). The avocado seeds have antioxidant and antimicrobial, antihypertensive, fungicidal, larvicidal, hypolipidemic, amoebicidal and giardicidal activities [76].
The present study indicated that AVSO contains many fatty acids and their derivatives (Table 6), such as linoleyl alcohol and carboxamide derived from palmitic acid and volatile compounds, for example, cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-, hexadecanamide, 9-octadecenamide, (Z)-, 2H-pyran and 2-(7-heptadecynyloxy)tetrahydro. AVSO includes steroids such as androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.) and the polycyclic aromatic hydrocarbon chrysene, octadecahydro. Also, its composition of 11-eicosenoic acid, monounsaturated omega-9 fatty, dl-.alpha.-tocopherol and gamma.-tocophero shows antioxidant activity. AVSO includes bicyclic organic compounds such as bicyclo[10.6.0]octadeca-1(12),15-diene as well as antitumor cis-10-nonadecenoic acid, monounsaturated fatty cis-10-nonadecenoic acid [77-79].
AVSO contains many essential and volatile oils, ester derivatives, farnesol isomer, heptacosane and 3-chloropropionic acid, heptadecyl este. Caryophyllene oxide has chemopreventative, anti-tumor and antifungal properties and is used in approved food flavoring and other benzyl, organic and aromatic derivatives, as indicated in Table 6 [80,81]. It yields antioxidant compounds such as oleic acid, stigmastan-3,5-diene and antifungal cosmetics agents such as sclaral (sclareolide lactol) [82].
Molecular docking is a theoretical simulation system based on bioinformatics, which depends on the cooperation between molecules (such as ligands and receptors) and predicts their binding modes and affinity by computer investigation. Molecular docking works as an acceptable tool in medicinal chemistry for fields such as structure-based analytical drugs. Various original studies corresponding to biomolecular cooperation in food pattern and phytochemistry have continuously evolved. The remarkable benefits of molecular docking, such as predicting procedures with fewer experiments and limiting the decline of material in trials, have led to the consideration of its possible administration in various areas. In docking complex binding energy, the lowest energy positions designate the highest binding affinity, as high energy creates variable conformations that assist in pharmacological experiments. Our previous work on rat and human investigations showed that the treatment effect of vitamin B and agarwood extracts confirmed by molecular docking might be due to their role as inverse agonists, reversing the induction of stress and depression by epinephrine with many medicinal properties, such as sedative, anti-inflammatory and anti-apoptotic effects [10]. The present work described the investigated compounds in the seed extracts have a potential binding mode with the β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) by docking analysis (Table 9,10). Further, the inhibitory effect of synergetic extract compounds was also reported. The present finding established the seed compounds’ ameliorating effect against both studied receptors and might represent the studied extract as an inverse agonist ligand for depression and infection in the COVID-19 pandemic.
We have future application possibilities in using the currently investigated seed oil extracts in manufacture as endogenous nanoparticles as drugs carrier or vaccines to target cell receptors and prolong their circulation time. Moreover, as the seed oil extract is present in fruit and is edible, it will help decrease the side effects that are likely to occur due to nanoparticles, vaccines and drugs in the surrounding and body tissue.
Many bioactive phytochemicals and herbal medicines have low solubility in aqueous media, poor bioavailability, poor stability and toxicity-dose dependence, so scientists have used nanotechnology to overcome these disadvantages and deliver bioactive phytochemicals to the target with higher efficiency, using encapsulation. For this goal, nanoparticles can be provided in various forms, sizes and combinations and adjusted physicochemically to accomplish particular characteristics, depending on the features of both the bioactive molecule and the target cell, such as an inorganic gold atom (molecular weight = 196.96657 g/mol) or organic liposome (molecular weight = 938.1 g/mol). Unfortunately, there are challenges such as the potential toxicity of nanoparticles, such as immunotoxicity, the toxicity of surfactants and co-surfactants or emulsifier nanocarriers, long-term toxicity due to chronic exposure and the accumulation as well as overaccumulation of nanoparticles at all barriers before acting on the targeted cells. The analyzed seed oil contents’ binding energy with the currently studied receptors enables them to be future nanoparticles in vaccines and drugs. Further, the molecular weight allows them to be nanocarriers [83-86].
Conclusion
In this investigation, the binding interactions of 44 phytoconstituents were carried out against the β2 adrenoreceptor (2rh1) and the ACE2 receptor, 3D0G. All the currently studied seed oil extract constituent were identified by gas chromatography-mass spectrometry and studied. The present investigation strongly suggests the application of these seed oil extracts to ameliorate depression and decrease and prevent infection in the COVID pandemic. Further studies need to be carried out to examine these compounds’ pharmacological properties and inhibitory potentials require experimental models.
Author Contributions
A.F.H. contributed to creating and owning, conceptualizing, work idea designing and performing the experiments, chromatography and AutoDock analysis, interpreting and analyzing data, writing, revising and editing the manuscript and explaining the results. T.M.F. contributed to the AutoDock analysis and formatting manuscript. I.M.A, I.A.K, M.E.O, M.A.A and F.M.A. contributed to the doing practical of the chromatography portion of the study.
Ethical Statement
This research did not include any human subjects or animal experiments.
References
- Ordoudi S, Bakirtzi C, Tsimidou M. The potential of tree fruit stone and seed wastes in greece as sources of bioactive ingredients. Recycling. 2018;3(1):9.
- Martin ME, Grao-Cruces E, Millan-Linares MC, Montserrat-de la Paz S. Grape (Vitis vinifera L.) Seed oil: a functional food from the winemaking industry. Foods. 2020;9(10):1360.
- Gorodyska O, Grevtseva N, Samokhvalova O, Gubsky S. Determination of the chemical composition of grape seed powders by GC-MS analysis. Eureka Life Sci. 2018;6(6):3-8.
- Felhi S, Baccouch N, Salah HB, Smaoui S, Allouche N, Gharsallah N, et al. Nutritional constituents, phytochemical profiles, in vitro antioxidant and antimicrobial properties and gas chromatography-mass spectrometry analysis of various solvent extracts from grape seeds (Vitis vinifera L.). Food Sci Biotechnol. 2016;25(6):1537-44.
- Yehualashet AS, Belachew TF. Aceis and arbs and their correlation with covid-19: A review. Infect Drug Resist. 2020;13:3217-24.
- Yu LL, Malik Peiris JS. Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol. 2005;17(4):404-10.
- Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020;144(5):213-21.
- Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week. J Am Coll Cardiol. 2020;75(24):3085-95.
- Mosli M, Alourfi M, Alamoudi A, Hashim A, Saadah O, Al Sulais E, et al. A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia. Saudi J Gastroenterol. 2020;26(5):263.
- Hamouda A. A pilot study of antistress effects of vitamin b complex and agarwood extract in an animal model with parallel observations on depression in human subjects. J Drug Alcohol Res. 2021;11.
- Lezama-Martínez D, Valencia-Hernández I, Flores-Monroy J, Martínez-Aguilar L. Combination of β adrenergic receptor block and renin–angiotensin system inhibition diminished the angiotensin II-induced vasoconstriction and increased bradykinin-induced vasodilation in hypertension. Dose-Response. 2017;15(4):1-7.
- Yonemochi H, Yasunaga S, Teshima Y, Iwao T, Akiyoshi K, Nakagawa M, et al. Mechanism of β-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C. Circulation. 1998;97(22):2268-73.
- Natesan V. SARS-CoV-2 host cell entry might involve beta adrenergic receptors. OSF Preprints. 2020.
- Chis IC, Ungureanu MI, Marton A, Simedrea R, Muresan A, Postescu ID, et al. Antioxidant effects of a grape seed extract in a rat model of diabetes mellitus. Diabetes Vasc Dis Res. 2009;6(3):200-4.
- Sreemantula S, Nammi S, Kolanukonda R, Koppula S, Boini KM. Adaptogenic and nootropic activities of aqueous extract of Vitis vinifera (grape seed): An experimental study in rat model. BMC Complement Altern Med. 2005;5(1):1.
- El-Awdan SA, Abdel Jaleel GA, Saleh DO. Grape seed extract attenuates hyperglycaemia-induced in rats by streptozotocin. Bull Fac Pharmacy, Cairo Univ. 2013;51(2):203-9.
- Monsefi M, Parvin F, Farzaneh M. Effects of plum extract on skeletal system of fetal and newborn mice. Med Princ Pract. 2013;22(4):351-6.
- Mirza MB, Elkady AI, Al-Attar AM, Syed FQ, Mohammed FA, Hakeem KR. Induction of apoptosis and cell cycle arrest by ethyl acetate fraction of Phoenix dactylifera L. (Ajwa dates) in prostate cancer cells. J Ethnopharmacol. 2018;218:35-44.
- Hamouda AF, Shaban NZ. Short and long term effects of pomegranate (Punica granatum) extracts on apoptosis in rat kidney induced by diethylnitrosamine and phenobarbital. J Pharm Pharmacol. 2016;4:52-63.
- Taha NA, Alkhawajah AAM, Raveesha KK. Acute and subacute toxicity studies of Persea americana Mill (Avocado) seed in rats. Int J Med Toxicol Leg Med. 2008;11(2):31-6.
- Khan TJ, Kuerban A, Razvi SS, Mehanna MG, Khan KA, Almulaiky YQ, et al. In-vivo evaluation of hypolipidemic and antioxidative effect of ‘Ajwa’(Phoenix dactylifera L.) date seed-extract in high-fat diet-induced hyperlipidemic rat model. Biomedicine and Pharmacotherapy. 2018;107:675-80.
- Egbuonu ACC, Omodamiro OD, Achi NK, Opara CI. Effect of ethanolic extract of avocado pear (persea americana) seed on normal and monosodium glutamate-compromised rats’ kidney histology and serum bio-functional parameters. EC Pharmacol Toxicol. 2017;4(6):271-84.
- Abdel-Moneim A, Ahmed OM, Fahim HI, Mohamed EE. The preventive effects of avocado fruit and seed extracts on cardio-nephrotoxicity induced by diethylnitrosamine/2-acetylaminoflurine in wistar rats. Basic Sci Med. 2017;6(1):4-13.
- Hamouda AF. A biochemical study of agarwood on methanol injection in rat. Ashdin Publ J Drug Alcohol Res. 2019;8(1):1-14.
- Umesh HR, Ramesh KV, Devaraju KS. Molecular docking studies of phytochemicals against trehalose-6-phosphate phosphatases of pathogenic microbes. Beni-Suef Univ J Basic Appl Sci. 2020;9(1):5.
- Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61.
- Tyagi R, Verma S, Mishra S, Srivastava M, Alam S, Khan F, et al. In-vitro and in silico studies of glycyrrhetinic acid derivatives as anti-filarial agents. Curr Top Med Chem. 2019;19(14):1191-200.
- Sehnal DR, Rose AS, Koca J, Burley S, Velankar S. Mol*: towards a common library and tools for web molecular graphics. Inworkshop on molecular graphics and visual analysis of molecular Data. The Eurographics Association. 2018.
- Harish BM, Devaraju KS, Gopi A, Saraswathi R, Babu RL, Chidananda Sharma S. In silico binding affinity study of calcineurin inhibitors to calcineurin and its close associates. Indian J Biotechnol. 2013;12:213-7.
- Sharma A, Batra A. Primary metabolite profiling of tinospora cordifolia. Nat Prod Chem Res. 2016;4(4):1-7.
- Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251-86.
- Hamouda AF, Sameeh MY, Shrourou RM. Effect of avocado (persea americana), cabbage (brassica oleracea) and ginger (zingiber officinale) on rat liver and thyroid injuries induced by CCl4 (Carbon Tetrachloride). J Pharm Pharmacol. 2016;4:108-18.
- Asmaa F Hamouda. Study on the effect of avocado on apoptosis, oxidative stress and injuries induced by diethyl nitrosamine in rat liver. J Pharm Pharmacol. 2015;3(5):243-52.
- Asmaa F Hamouda, Nadia Z Shaban. Short and long term effects of pomegranate (punica granatum) extracts on apoptosis in rat kidney induced by diethylnitrosamine and phenobarbital. J Pharm Pharmacol. 2016;4(2):52-63.
- Hamouda A, Shaban N, Talaat I. Effects of some pyrimidine derivatives and pomegranate juice on male rat kidney injuries induced by diethylnitrosamine and carbon tetrachloride. Biol Chem Res. 2015;2015:215-29.
- Martin ME, Grao-Cruces E, Millan-Linares MC, Montserrat-de la Paz S. Grape (Vitis vinifera L.) seed oil: a functional food from the winemaking industry. Foods. 2020;9(10):1360.
- Gorodyska O, Grevtseva N, Samokhvalova O, Gubsky S. Determination of the chemical composition of grape seed powders by gc-ms analysis. Eureka Life Sci. 2018;6(6):3-8.
- Felhi S, Baccouch N, Salah HB, Smaoui S, Allouche N, Gharsallah N, Kadri A. Nutritional constituents, phytochemical profiles, in-vitro antioxidant and antimicrobial properties and gas chromatography-mass spectrometry analysis of various solvent extracts from grape seeds (Vitis vinifera L.). Food Sci Biotechnol. 2016;25(6):1537-44.
- McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005;74(1):411-32.
- Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, et al. Chemical characterization of a family of brain lipids that induce sleep. Science. 1995;268(5216):1506-9.
- Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG. Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol. 2005;146(7):917-26.
- Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, et al. The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐and Δ9‐tetrahydrocannabivarin in mice in-vivo. Br J Pharmacol. 2007;150(5):586-94.
- Brocks JJ, Jarrett AJM, Sirantoine E, Hallmann C, Hoshino Y, Liyanage T. The rise of algae in Cryogenian oceans and the emergence of animals. Nature. 2017;548(7669):578-81.
- Ohara T, Sato T, Shimizu N, Prescher G, Schwind H, Weiberg O, et al. Acrylic acid and derivatives. in: ullmann’s encyclopedia of industrial chemistry. Wiley. 2020;1-21.
- Coessens V, Pintauer T, Matyjaszewski K. Functional polymers by atom transfer radical polymerization. Prog Polym Sci. 2001.
- Joo SS, Kim YB, Lee DI. Antimicrobial and antioxidant properties of secondary metabolites from white rose flower. Plant Pathol J. 2010;26(1):57-62.
- Gad SE, Barbare R. Phosphoric acid. In: Encyclopedia of Toxicology. Elsevier; 2005:414-5.
- Markowiak-Kopeć P, Śliżewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020;12(4):1107.
- McDonald JA, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, et al. Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology. 2018;155(5):1495-507.
- Hunter JE, Zhang J, Kris-Etherton PM, Childs L. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated and unsaturated fatty acids: A systematic review. Am J Clin Nutr. 2010;91(1):46-63.
- Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos MJ, et al. Re‐evaluation of fatty acids (E 570) as a food additive. EFSA J. 2017;15(5):4785.
- Rodrigues B, Sawant A. Anti-microbial and anti-cancer activity of setosphaeria monoceras, an endophytic fungus associated with tropical mangrove plant. World J Pharm Pharm Sci. 2018;6(6):1315-29.
- Sharma D, Pramanik A, Agrawal PK. Evaluation of bioactive secondary metabolites from endophytic fungus pestalotiopsis neglecta BAB-5510 isolated from leaves of cupressus torulosa D. 3-Biotech. 2016;6(2):210.
- Devi N, Singh M. GC-MS analysis of metabolites from endophytic fungus collectotrichum gloeosporiodes isolated from phlogacanthus thyrsiflorus. Int J Pharm Sci Rev Res. 2013;23(2):392-5.
- Yadav A, Yadav M, Kumar S, Sharma D, Yadav JP. In-vitro antioxidant activities and GC-MS analysis of different solvent extracts of acacia nilotica leaves. Indian J Pharm Sci. 2018;80(5):892-902.
- Yoshihara S, Mizutare T, Makishima M, Suzuki N, Fujimoto N, Igarashi K, et al. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: Their structures and estrogenic potency. Toxicol Sci. 2004;78(1):50-9.
- Okuda K, Takiguchi M, Yoshihara S. In-vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol Lett. 2010;197(1):7-11.
- Jasiem TM, Nasser NM, Baderden SK, Hasan HA. Pharmacognostical and phytochemical studies of Iraqi hibiscus rosa-sinensis. In: AIP Conference Proceedings. American Institute of Physics Inc. 2019;2144:1-6.
- Huang B, Ban X, He J, Tong J, Tian J, Wang Y. Comparative analysis of essential oil components and antioxidant activity of extracts of Nelumbo nucifera from various areas of China. J Agric Food Chem. 2010;58(1):441-8.
- González-García E, Marina ML, García MC. Plum (Prunus Domestica L.) by-product as a new and cheap source of bioactive peptides: Extraction method and peptides characterization. J Funct Foods. 2014;11:428-37.
- Savić IM, Nikolić VD, Savić-Gajić IM, Kundaković TD, Stanojković TP, Najman SJ. Chemical composition and biological activity of the plum seed extract. Adv Technol. 2016;5(2):38-45.
- Fotschki B, Jurgoński A, Juśkiewicz J, Zduńczyk Z. Metabolic effects of dietary apple seed oil in rats. Zywn Nauk Technol Jakosc. 2015;198:220-31.
- Jurgoński A, Juśkiewicz J, Zduńczyk Z. A high-fat diet differentially affects the gut metabolism and blood lipids of rats depending on the type of dietary fat and carbohydrate. Nutrients. 2014;6(2):616-26.
- Lunn J, Theobald HE. The health effects of dietary unsaturated fatty acids. Nutr Bull. 2006;31(3):178-224.
- Manosso LM, Neis VB, Moretti M, Daufenbach JF, Freitas AE, Colla AR, et al. Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α. Prog Neuro-Psychopharmacology Biol Psychiatry. 2013;46:48-57.
- Djoussé L, Matthan NR, Lichtenstein AH, Gaziano JM. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am J Cardiol. 2012;110(4):539-44.
- Field CJ, Blewett HH, Proctor S, Vine D. Human health benefits of vaccenic acid. Appl Physiol Nutr Metab. 2009;34(5):979-91.
- Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Brain Res Bull. 2016;126(1):111-26.
- Abdulmalik O, Safo MK, Chen Q, Yang J, Brugnara C, Ohene‐Frempong K, et al. 5-Hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol. 2005;128(4):552-61.
- Priyadarshi S, Khanum H, Ravi R, Borse BB, Naidu MM. Flavour characterisation and free radical scavenging activity of coriander (Coriandrum sativum L.) foliage. J Food Sci Technol. 2016;53(3):1670-8.
- Čechovská L, Cejpek K, Konečný M, Velíšek J. On the role of 2,3-dihydro-3,5-dihydroxy-6-methyl-(4H)-pyran-4-one in antioxidant capacity of prunes. Eur Food Res Technol. 2011;233(3):367-76.
- Olowokere JA, Onen AI, Odineze MC, B’aga ID, Kefas EG. Extraction and characterization of oil from date palm (phoenix dactylifera) seed. Asian J Appl Chem Res. 2019;3(4):1-9.
- Alqarni MMM, Osman MA, Al-Tamimi DS, Gassem MA, Al‐Khalifa AS, Al‐Juhaimi F, et al. Antioxidant and antihyperlipidemic effects of Ajwa date (Phoenix dactylifera L.) extracts in rats fed a cholesterol-rich diet. J Food Biochem. 2019;43(8):e12933.
- Junwei L, Juntao C, Changyu N, Peng W. Molecules and functions of rosewood: Pterocarpus cambodianus. Arab J Chem. 2018;11(6):763-70.
- Tabeshpour J, Razavi BM, Hosseinzadeh H. Effects of avocado (persea americana) on metabolic syndrome: a comprehensive systematic review. Phyther Res. 2017;31(6):819-37.
- Bahru T, Tadele Z, Ajebe E. A review on avocado seed: functionality, composition, antioxidant and antimicrobial properties. Chem Sci Int J. 2019;27(2):1-10.
- Alam EA. Volatile compounds of egyptian fruits of rumex vesicarius l. Int J Pharm Pharm Sci. 2014;6(3):18-9.
- Fukuzawa M, Yamaguchi R, Hide I, Chen Z, Hirai Y, Sugimoto A, et al. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008;31(10):1933-7.
- Iijima H, Kasai N, Chiku H, Murakami S, Sugawara F, Sakaguchi K, et al. The inhibitory action of long-chain fatty acids on the DNA binding activity of p53. Lipids. 2006;41(6):521-7.
- Joo JH, Jetten AM. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 2010;287(2):123-35.
- Elsayed TR, Galil DF, Sedik MZ, Hassan HMM, Sadik MW. Antimicrobial and anticancer activities of actinomycetes isolated from Egyptian soils. Int J Curr Microbiol Appl Sci. 2020;9(9):1689-700.
- Jasiński M, Stukkens Y, Degand H, Purnelle B, Marchand-Brynaert J, Boutry M. A plant plasma membrane ATP binding cassette-type transporter is involved in antifungal terpenoid secretion. Plant Cell. 2001;13(5):1095-1107.
- Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25(4):363-76.
- Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm. 2011;8(6):2101-41.
- Sarker SD, Nahar L. Application of nanotechnology in phytochemical research. Pharm Sci. 2017;23(3):170-1.
- Wei A, Mehtala JG, Patri AK. Challenges and opportunities in the advancement of nanomedicines. J Control Release. 2012;164(2):236-46.
This work is licensed under Attribution-NonCommercial-NoDerivs 2.0 Generic (CC BY-NC-ND 2.0) International License. With this license readers are free to share, copy and redistribute the material in any medium or format as long as the original source is properly cited.
Author Info
Asmaa Fathi Hamouda1,2*, Taymour-Lank Mohammed Farawilla3, Ibraheem Mohammed Attafi4, Ibrahim Abdu Khardali4, Mohammad Ahmad Attafi4, Magbool Essa Oraiby4, Farid Mohammad Abualsail4
1Department of Biochemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
2Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia
3Department of Chemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
4Poison Control and Medical Forensic Chemistry Center, Ministry of Health, Jazan, Kingdom of Saudi Arabia
*Corresponding Author: Asmaa Fathi Hamouda, Alexandria University, Egypt, Assistant Professor in the Umm Al-Qura University, Saudi Arabia (2014-2016) and Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia, Email: [email protected]
Copyright
Copyright© 2021 by Hamouda AF, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation
Citation: Hamouda AF, et al. Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic. J Clin Med Res. 2021;2(2) :1-65.